☰

Stuart J. Russell - Publications

Affiliations: 
Electrical Engineering and Computer Science University of California, Berkeley, Berkeley, CA, United States 
Area:
Artificial Intelligence (AI); Control, Intelligent Systems, and Robotics (CIR); Biosystems & Computational Biology (BIO); machine learning; real-time decision-making; algorithms; probabilistic reasoning; computational biology
Tree Info Similar researchers PubMed Report error

15/500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Bras RL, Arora N, Kushida N, Mialle P, Bondár I, Tomuta E, Alamneh FK, Feitio P, Villarroel M, Vera B, Sudakov A, Laban S, Nippress S, Bowers D, Russell S, et al. NET-VISA from Cradle to Adulthood. A Machine-Learning Tool for Seismo-Acoustic Automatic Association Pure and Applied Geophysics. 1-22. DOI: 10.1007/S00024-020-02508-X  0.626
2017 Russell S. Artificial intelligence: The future is superintelligent Nature. 548: 520-521. DOI: 10.1038/548520A  0.326
2015 Russell S, Dietterich T, Horvitz E, Selman B, Rossi F, Hassabis D, Legg S, Suleyman M, George D, Phoenix S. Letter to the Editor: Research Priorities for Robust and Beneficial Artificial Intelligence: An Open Letter Ai Magazine. 36: 3. DOI: 10.1609/Aimag.V36I4.2621  0.351
2015 Russell S, Dewey D, Tegmark M. Research Priorities for Robust and Beneficial Artificial Intelligence Ai Magazine. 36: 105-114. DOI: 10.1609/Aimag.V36I4.2577  0.3
2013 Arora NS, Russell S, Sudderth E. NET-VISA: Network processing vertically integrated seismic analysis Bulletin of the Seismological Society of America. 103: 709-729. DOI: 10.1785/0120120107  0.619
2010 Aha DW, Boddy M, Bulitko V, D'Avila Garcez AS, Doshi P, Edelkamp S, Geib C, Gmytrasiewicz P, Goldman RP, Halevy A, Hitzler P, Isbell C, Josyula D, Kaelbling LP, Kersting K, ... ... Russell S, et al. Reports of the AAAI 2010 conference workshops Ai Magazine. 31: 95-104. DOI: 10.1609/Aimag.V31I4.2318  0.597
1998 Huang T, Russell S. Object identification: a Bayesian analysis with application to traffic surveillance Artificial Intelligence. 103: 77-93. DOI: 10.1016/S0004-3702(98)00067-8  0.325
1997 Binder J, Koller D, Russell S, Kanazawa K. Adaptive Probabilistic Networks with Hidden Variables Machine Learning. 29: 213-244. DOI: 10.1023/A:1007421730016  0.301
1997 Russell SJ. Rationality and intelligence Artificial Intelligence. 94: 57-77. DOI: 10.1016/S0004-3702(97)00026-X  0.34
1996 Russell S. Chapter 4 – Machine Learning Artificial Intelligence. 89-133. DOI: 10.1016/B978-012161964-0/50006-6  0.339
1996 Zilberstein S, Russell S. Optimal composition of real-time systems Artificial Intelligence. 82: 181-213. DOI: 10.1016/0004-3702(94)00074-3  0.318
1994 Russell SJ, Subramanian D. Provably bounded-optimal agents Journal of Artificial Intelligence Research. 2: 575-609. DOI: 10.1613/Jair.133  0.632
1991 Russell SJ. An architecture for bounded rationality Intelligence\/Sigart Bulletin. 2: 146-150. DOI: 10.1145/122344.122374  0.305
1991 Russell SJ. Prior knowledge and autonomous learning Robotics and Autonomous Systems. 8: 145-159. DOI: 10.1016/0921-8890(91)90019-H  0.324
1991 Russell S. Principles of metareasoning Artificial Intelligence. 49: 361-395. DOI: 10.1016/0004-3702(91)90015-C  0.34
Low-probability matches (unlikely to be authored by this person)
1998 Tadepalli P, Russell S. Learning from Examples and Membership Queries with Structured Determinations Machine Learning. 32: 245-295. DOI: 10.1023/A:1007421315813  0.297
2012 Sivaganesan A, Erol Y, Manley GT, Russell S. 146 Modeling and Machine Learning of Cerebrovascular Dynamics: A Framework for Monitoring Unmeasurable Patient Variables Neurosurgery. 71. DOI: 10.1227/01.Neu.0000417736.01677.Be  0.288
2016 Chen H, Erol Y, Shen E, Russell S. Probabilistic model-based approach for heart beat detection. Physiological Measurement. 37: 1404-1421. PMID 27480267 DOI: 10.1088/0967-3334/37/9/1404  0.284
1995 Russell S, Norvig P. A modern, agent-oriented approach to introductory artificial intelligence Intelligence\/Sigart Bulletin. 6: 24-26. DOI: 10.1145/201977.201989  0.281
2009 Russell S, Saul L. Technical perspectiveThe ultimate pilot program Communications of the Acm. 52: 96-96. DOI: 10.1145/1538788.1538811  0.28
2015 Russell S. Recent developments in unifying logic and probability Communications of the Acm. 58: 88-97. DOI: 10.1145/2699411  0.268
1991 Russell S. Inductive learning by machines Philosophical Studies. 64: 37-64. DOI: 10.1007/Bf00356089  0.259
2009 Oh S, Russell S, Sastry S. Markov Chain Monte Carlo Data Association for Multi-Target Tracking Ieee Transactions On Automatic Control. 54: 481-497. DOI: 10.1109/Tac.2009.2012975  0.258
2016 Russell S. Should We Fear Supersmart Robots? Scientific American. 314: 58-59. DOI: 10.1038/Scientificamerican0616-58  0.232
1987 Russell SJ. Rationality as an explanation of language Behavioral and Brain Sciences. 10: 730-731. DOI: 10.1017/S0140525X00055552  0.207
1997 Russell SJ, Stiller L, Hansson O. PNPACK: Computing with probabilities in Java Concurrency and Computation: Practice and Experience. 9: 1333-1339. DOI: 10.1002/(Sici)1096-9128(199711)9:11<1333::Aid-Cpe359>3.0.Co;2-V  0.2
2015 Moore DA, Russell SJ. Gaussian process random fields Advances in Neural Information Processing Systems. 2015: 3357-3365.  0.164
2024 Cohen MK, Kolt N, Bengio Y, Hadfield GK, Russell S. Regulating advanced artificial agents. Science (New York, N.Y.). 384: 36-38. PMID 38574134 DOI: 10.1126/science.adl0625  0.156
2022 Doya K, Ema A, Kitano H, Sakagami M, Russell S. Social impact and governance of AI and neurotechnologies. Neural Networks : the Official Journal of the International Neural Network Society. 152: 542-554. PMID 35671575 DOI: 10.1016/j.neunet.2022.05.012  0.144
2009 Dispenzieri A, Gertz MA, Hayman SR, Buadi F, Kumar S, Reeder CB, Zeldenrust SR, Rajkumar S, Detweiler-Short K, Lust JA, Witzig TE, Greipp PR, Russell SJ, Dingli D, Allred J, et al. A Pilot Study of Pomalidomide and Dexamethasone in Previously Treated Light Chain Amyloidosis Patients. Blood. 114: 3854-3854. DOI: 10.1182/Blood.V114.22.3854.3854  0.142
2012 Naik S, Nace R, Barber GN, Russell SJ. Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-Β Cancer Gene Therapy. 19: 443-450. PMID 22522623 DOI: 10.1038/Cgt.2012.14  0.14
2012 Kapoor P, Kumar S, Gertz MA, Lacy M, Dingli D, Russell SJ, Buadi F, Zeldenrust SR, Lust JA, Hayman SR, Kyle RA, Rajkumar V, Dispenzieri A. Does stage migration exist in active multiple myeloma (MM)? Journal of Clinical Oncology. 30: 8105-8105. DOI: 10.1200/JCO.2012.30.15_SUPPL.8105  0.139
2009 Lacy MQ, Gertz MA, Hayman SR, Short KD, Dispenzieri A, Kumar S, Zeldenrust SR, Greipp PR, Lust JA, Russell SJ, Buadi F, Kyle R, Fonseca R, Bergsagel PL, Roy V, et al. Pomalidomide (CC4047) Plus Low Dose Dexamethasone (Pom/dex) Is Active and Well Tolerated in Lenalidomide Refractory Multiple Myeloma (MM). Blood. 114: 429-429. DOI: 10.1182/BLOOD.V114.22.429.429  0.138
2006 Dispenzieri A, Lacy M, Zeldenrust S, Hayman SR, Kumar S, Geyer SM, Lust JA, Allred JB, Witzig TE, Rajkumar SV, Greipp PR, Russell SJ, Kabat B, Gertz MA. Cardiac Biomarkers Predict for Ability To Tolerate and Complete Therapy with Lenalidomide ± Dexamathosone in AL Amyloidosis. Blood. 108: 130-130. DOI: 10.1182/Blood.V108.11.130.130  0.138
2019 Nandakumar B, Kumar SK, Buadi FK, Dispenzieri A, Dingli D, Lacy MQ, Kapoor P, Lin Y, Kourelis T, Muchtar E, Lust JA, Russell SJ, Go RS, Warsame RM, Hayman SR, et al. Clinical Outcomes and Cytogenetic Features of Primary Plasma Cell Leukemia (pPCL) in the Era of Novel Agent Induction Therapy Blood. 134: 5490-5490. DOI: 10.1182/Blood-2019-126057  0.136
2007 Dispenzieri A, Lacy MQ, Zeldenrust SR, Hayman SR, Kumar SK, Geyer SM, Lust JA, Allred JB, Witzig TE, Rajkumar SV, Greipp PR, Russell SJ, Kabat B, Gertz MA. The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis. Blood. 109: 465-70. PMID 17008538 DOI: 10.1182/Blood-2006-07-032987  0.136
2016 Tandon N, Sidana S, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Dingli D, Fonder A, Hayman SR, Hobbs M, Gonsalves WI, Kapoor P, Hwa YL, Kyle RA, Leung N, ... ... Russell SJ, et al. Predictors of Early Relapse Following Initial Therapy for Systemic Immunoglobulin Light Chain Amyloidosis Blood. 128: 2082-2082. DOI: 10.1182/Blood.V128.22.2082.2082  0.135
2018 Lacy MQ, Peng K, Russell SJ, Dueck AC, Patnaik MM, Witzig TE, Ginos BF, Buadi FK, Dispenzieri A, Gertz MA, Go RS, Hayman SR, Lust JA, Dingli D, Rajkumar SV, et al. Phase I Trial of Systemic Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and Human Interferon, in Patients with Relapsed or Refractory Multiple Myeloma (MM), Acute Myeloid Leukemia (AML), and T-Cell Neoplasms (TCL) Blood. 132: 3268-3268. DOI: 10.1182/Blood-2018-99-119444  0.134
2015 Russell S, Bohannon J. Artificial intelligence. Fears of an AI pioneer. Science (New York, N.Y.). 349: 252. PMID 26185241 DOI: 10.1126/science.349.6245.252  0.134
2019 Buadi FK, Lacy MQ, Dispenzieri A, Perez G, Gertz MA, Kapoor P, Hayman SR, Dingli D, Go RS, Fonder A, Hwa YL, Hobbs MA, Gonsalves WI, Helgeson DK, Kourelis T, ... ... Russell SJ, et al. Phase 2 Trial of LDE225 and Lenalidomide Maintenance Post Autologous Stem Cell Transplant for Multiple Myeloma Blood. 134: 1905-1905. DOI: 10.1182/Blood-2019-132035  0.133
2013 Dispenzieri A, Stewart AK, Chanan-Khan A, Rajkumar SV, Kyle RA, Fonseca R, Kapoor P, Bergsagel PL, McCurdy A, Gertz MA, Lacy MQ, Lust JA, Russell SJ, Zeldenrust SR, Reeder C, et al. Smoldering multiple myeloma requiring treatment: time for a new definition? Blood. 122: 4172-81. PMID 24144641 DOI: 10.1182/Blood-2013-08-520890  0.132
2004 Rajkumar SV, Hayman SR, Lacy MQ, Dispenzieri A, Hoering A, Geyer SM, Zeldenrust SR, Greipp PR, Fonseca R, Lust JA, Russell SJ, Kyle RA, Witzig TE, Gertz MA. Combination Therapy with CC-5013 (Lenalidomide; Revlimid™) Plus Dexamethasone (Rev/Dex) for Newly Diagnosed Myeloma (MM). Blood. 104: 331-331. DOI: 10.1182/Blood.V104.11.331.331  0.132
2007 Dispenzieri A, Myers RM, Tong C, Greiner SM, Harvey ME, Griesmann G, Reid J, Federspiel M, Ames MM, Dingli D, Lacy MQ, Gertz MA, Schweikwart K, Welch A, Peng K, ... Russell SJ, et al. Pre-Clinical Data and Preliminary Patient Results of Intravenous MV-NIS To Treat Relapsed, Refractory Multiple Myeloma. Blood. 110: 1181-1181. DOI: 10.1182/BLOOD.V110.11.1181.1181  0.132
2012 Kumar SK, Dispenzieri A, Gertz MA, Lacy MQ, Lust JA, Hayman SR, Buadi FK, Dingli D, Zeldenrust SR, Russell S, Kapoor P, Lin Y, Hwa L, Larson D, Colby CL, et al. Continued Improvement in Survival in Multiple Myeloma and the Impact of Novel Agents Blood. 120: 3972-3972. DOI: 10.1182/Blood.V120.21.3972.3972  0.132
2009 Buadi F, Lacy MQ, Dispenzieri A, Kumar S, Hayman S, Short KED, Dingli D, Zeldenrust SR, Greipp PR, Lust JA, Russell SJ, Kyle R, Rajkumar V, Gertz MA. Retrospective Study of the Efficacy of Bortezomib in Primary Systemic Amyloidosis. Blood. 114: 4953-4953. DOI: 10.1182/BLOOD.V114.22.4953.4953  0.131
2008 Dispenzieri A, Lacy M, Zeldenrust SR, Hayman SR, Kumar SK, Lust JA, Allred J, Rajkumar SV, Greipp PR, Laumann K, Russell S, Buadi F, Witzig TE, Gertz MA. Long Term Follow-up of Patients with Immunoglobulin Light Chain Amyloidosis Treated with Lenalidomide and Dexamethasone. Blood. 112: 1737-1737. DOI: 10.1182/Blood.V112.11.1737.1737  0.131
2019 Evans LA, Jevremovic D, Nandakumar B, Buadi FK, Dispenzieri A, Dingli D, Lacy MQ, Hayman SR, Kapoor P, Go RS, Leung N, Fonder A, Hobbs MA, Hwa YL, Muchtar E, ... ... Russell SJ, et al. Utilizing Multiparametric Flow Cytometry to Identify Patients with Primary Plasma Cell Leukemia at Diagnosis Blood. 134: 4334-4334. DOI: 10.1182/Blood-2019-126777  0.13
2017 Warsame R, Laplant B, Laumann K, Kumar SK, Gertz MA, Kyle RA, Lacy MQ, Dingli D, Leung N, Buadi FK, Hayman SR, Kapoor P, Hwa YL, Fonder A, Hobbs M, ... ... Russell SJ, et al. Long-Term Outcomes of IMiD Based Trials in Patients with Immunoglobulin Light Chain Amyloidosis (AL): A Pooled Analysis Blood. 130: 1833-1833. DOI: 10.1182/Blood.V130.Suppl_1.1833.1833  0.129
2013 A Gertz M, Hayman SR, Dingli D, Dispenzieri A, Kapoor P, Kumar SK, Lacy MQ, Leung N, Lin Y, Lust JA, Mikhael JR, Rajkumar SV, Russell SJ, Zeldenrust SR, Kyle R, et al. Therapy Related MDS/AML In Multiple Myeloma Patients In The Era Of Novel Agents Blood. 122: 3117-3117. DOI: 10.1182/Blood.V122.21.3117.3117  0.128
2013 Bailey K, Kirk A, Naik S, Nace R, Steele MB, Suksanpaisan L, Li X, Federspiel MJ, Peng KW, Kirk D, Russell SJ. Mathematical model for radial expansion and conflation of intratumoral infectious centers predicts curative oncolytic virotherapy parameters. Plos One. 8: e73759. PMID 24040057 DOI: 10.1371/Journal.Pone.0073759  0.126
2018 Binder M, Rajkumar SV, Lakshman A, Lacy MQ, Gertz MA, Buadi FK, Dispenzieri A, Hwa L, Fonder A, Hobbs M, Hayman SR, Zeldenrust S, Lust JA, Russell SJ, Leung N, et al. Expected Survival in Patients with Smoldering Multiple Myeloma and Multiple Myeloma Blood. 132: 4497-4497. DOI: 10.1182/Blood-2018-99-118084  0.126
2005 Dingli D, Cascino MD, Josić K, Russell SJ, Bajzer Z. Mathematical modeling of cancer radiovirotherapy. Mathematical Biosciences. 199: 55-78. PMID 16376950 DOI: 10.1016/J.MBS.2005.11.001  0.126
2016 Boyiadzis M, Bishop MR, Abonour R, Anderson KC, Ansell SM, Avigan D, Barbarotta L, Barrett AJ, Van Besien K, Bergsagel PL, Borrello I, Brody J, Brufsky J, Cairo M, Chari A, ... ... Russell SJ, et al. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia. Journal For Immunotherapy of Cancer. 4: 90. PMID 28018601 DOI: 10.1186/s40425-016-0188-z  0.125
2013 LeBlanc AK, Naik S, Galyon GD, Jenks N, Steele M, Peng KW, Federspiel MJ, Donnell R, Russell SJ. Safety studies on intravenous administration of oncolytic recombinant vesicular stomatitis virus in purpose-bred beagle dogs. Human Gene Therapy. Clinical Development. 24: 174-81. PMID 24219832 DOI: 10.1089/humc.2013.165  0.125
2005 Goel A, Dispenzieri A, Geyer SM, Greiner S, Russell SJ. Synergistic Activity of the Proteasome Inhibitor PS-341 with Non-Myeloablative 153-Sm-EDTMP in a Syngeneic, Orthotopic Model of Multiple Myeloma. Blood. 106: 3453-3453. DOI: 10.1182/Blood.V106.11.3453.3453  0.124
2015 Chakraborty R, Gertz MA, Dispenzieri A, Gonsalves WI, Go RS, Hayman SR, Hwa YL, Kapoor P, Kyle RA, Lacy MQ, Leung N, Rajkumar SV, Russell SJ, Zeldenrust SR, Kumar S. Natural History of Amyloidosis Isolated to Fat and Bone Marrow Aspirate Blood. 126: 5303-5303. DOI: 10.1182/Blood.V126.23.5303.5303  0.124
2016 Ravi P, Kumar S, Gonsalves WI, Buadi FK, Lacy MQ, Go RS, Dispenzieri A, Kapoor P, Lust JA, Dingli D, Lin Y, Russell SJ, Leung N, Gertz MA, Kyle RA, et al. Changes in Uninvolved Immunoglobulins during Multiple Myeloma Therapy Blood. 128: 3251-3251. DOI: 10.1182/Blood.V128.22.3251.3251  0.124
2015 Yui J, Van Keer J, Vij R, Jhaveri K, Kastritis E, Buadi F, Dispenzieri A, Dingli D, Russell SJ, Leung N. Thrombotic Microangiopathy in Multiple Myeloma Blood. 126: 5317-5317. DOI: 10.1182/BLOOD.V126.23.5317.5317  0.123
2013 Rajkumar SV, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Dingli D, Hayman SR, Kapoor P, McCurdy A, Leung N, Russell S, Lust JA, Zeldenrust SR, Lin Y, Kyle R, et al. Incidence and Survival Outcomes Of Extramedullary Myeloma Blood. 122: 3141-3141. DOI: 10.1182/Blood.V122.21.3141.3141  0.123
2016 Sidana S, Tandon N, Dispenzieri A, Gertz MA, Buadi F, Lacy MQ, Dingli D, Fonder A, Hayman SR, Hobbs M, Gonsalves WI, Hwa YL, Kapoor P, Kyle RA, Leung N, ... ... Russell SJ, et al. Bortezomib Versus Non-Bortezomib Based Treatment for Transplant Ineligible Patients with Light Chain Amyloidosis Blood. 128: 3317-3317. DOI: 10.1182/Blood.V128.22.3317.3317  0.123
2007 Dispenzieri A, Rajkumar SV, Gertz MA, Fonseca R, Lacy MQ, Bergsagel PL, Kyle RA, Greipp PR, Witzig TE, Reeder CB, Lust JA, Russell SJ, Hayman SR, Roy V, Kumar S, et al. Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement. Mayo Clinic Proceedings. 82: 323-41. PMID 17352369 DOI: 10.4065/82.3.323  0.122
2010 Kumar S, Gertz M, Lacy M, Dingli D, Hayman SR, Buadi F, Detweiler-Short K, Zeldenrust S, Leung N, Greipp PR, Lust J, Russell S, Kyle R, Rajkumar V, Dispenzieri A. Recent Improvements In Survival In Light Chain Amyloidosis and the Importance of An Early Mortality Risk Score Blood. 116: 1892-1892. DOI: 10.1182/BLOOD.V116.21.1892.1892  0.122
2016 Tandon N, Sidana S, Dispenzieri A, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Fonder A, Hayman SR, Hobbs M, Kapoor P, Gonsalves WI, Hwa YL, Kyle RA, Go RS, ... ... Russell SJ, et al. Effect of Standard Dose Versus Risk Adapted Melphalan Conditioning on Outcomes in Systemic AL Amyloidosis Patients Undergoing Frontline Autologous Stem Cell Transplant Based on Revised Mayo Stage Blood. 128: 4627-4627. DOI: 10.1182/Blood.V128.22.4627.4627  0.121
2013 Painuly U, Pandey S, Kumar SK, Kyle R, Lacy MQ, Gertz MA, Rajkumar V, Hayman SR, Buadi F, Dingli D, Russell SJ, Lust JA, McCurdy A, Dispenzieri A, Kapoor P. Survival Outcomes Of Very Young (<40 years) Myeloma Patients Blood. 122: 2136-2136. DOI: 10.1182/BLOOD.V122.21.2136.2136  0.121
2015 Majithia N, Vincent Rajkumar S, Lacy MQ, Buadi FK, Dispenzieri A, Gertz MA, Hayman SR, Dingli D, Kapoor P, Hwa L, Lust JA, Russell SJ, Go RS, Kyle RA, Kumar SK. Outcomes of primary refractory multiple myeloma and the impact of novel therapies. American Journal of Hematology. 90: 981-5. PMID 26214732 DOI: 10.1002/Ajh.24131  0.121
2011 Kapoor P, Gertz MA, Rajkumar SV, Lacy MQ, Dingli D, Hayman SR, Russell SJ, Lust JA, Buadi FK, Zeldenrust SR, Greipp PR, Dispenzieri A, Kyle RA, Kumar S. Survival Outcome of Young Multiple Myeloma (MM) Patients in the Era of Novel Therapies Blood. 118: 2950-2950. DOI: 10.1182/Blood.V118.21.2950.2950  0.12
2013 Paludo J, Painuly U, Kumar S, Buadi F, Hayman SR, Lacy MQ, Dispenzieri A, Lust JA, Dingli D, McCurdy A, Russell SJ, Leung N, Zeldenrust SR, Rajkumar V, Gertz MA, et al. Myelomatous Involvement Of The Central Nervous System: Mayo Clinic Experience Blood. 122: 3119-3119. DOI: 10.1182/BLOOD.V122.21.3119.3119  0.12
2009 Russell SJ, Peng KW. Measles virus for cancer therapy. Current Topics in Microbiology and Immunology. 330: 213-41. PMID 19203112 DOI: 10.1007/978-3-540-70617-5_11  0.119
2016 Sidana S, Tandon N, Dispenzieri A, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Fonder A, Hayman SR, Hobbs M, Gonsalves WI, Hwa YL, Kapoor P, Kyle RA, Leung N, ... ... Russell SJ, et al. Impact of Melphalan-Based Chemotherapy on Stem Cell Collection in Patients with Light Chain Amyloidosis Blood. 128: 2187-2187. DOI: 10.1182/Blood.V128.22.2187.2187  0.119
2008 Lacy MQ, Hayman SR, Gertz MA, Allred JB, Mandrekar SJ, Dispenzieri A, Zeldenrust SR, Kumar S, Greipp PR, Lust JA, Russell SJ, Buadi F, Kyle RA, Bergsagel PL, Fonseca R, et al. Pomalidomide (CC4047) Plus Low-Dose Dexamethasone (Pom/dex) Is Highly Effective Therapy in Relapsed Multiple Myeloma Blood. 112: 866-866. DOI: 10.1182/Blood.V112.11.866.866  0.119
2011 Kumar SK, Lacy MQ, Hayman SR, Stewart K, Buadi FK, Allred J, Laumann K, Greipp PR, Lust JA, Gertz MA, Zeldenrust SR, Bergsagel PL, Reeder CB, Witzig TE, Fonseca R, ... Russell SJ, et al. Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: results from a phase 2 trial. American Journal of Hematology. 86: 640-5. PMID 21630308 DOI: 10.1002/Ajh.22053  0.118
2018 Muchtar E, Therneau T, Larson D, Gertz MA, Lacy MQ, Buadi FK, Dingli D, Hayman SR, Kapoor P, Gonsalves WI, Kourelis T, Warsame R, Fonder A, Hobbs M, Hwa YL, ... ... Russell SJ, et al. Comparative Analysis of Staging Systems in AL Amyloidosis Blood. 132: 3228-3228. DOI: 10.1182/BLOOD-2018-99-114262  0.118
2018 Bakkum-Gamez J, Block MS, Packiriswamy N, Brunton BA, Deepak U, Mitchell JM, Suksanpaisan L, Atherton P, Dueck A, Russell SJ, Lacy MQ, Peng K. Abstract CT072: First in human (FIH) dose escalation studies of intravenous administration of VSV-IFNβ-NIS (Voyager-V1™) in Stage IV or recurrent endometrial cancer Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Ct072  0.118
2010 Chee CE, Rajkumar SV, Gertz MAA, Lacy M, Zeldenrust S, Kumar S, Hayman SR, Buadi F, Russell S, Kyle R, Greipp PR, Dispenzieri A. Higher Plasma Cell Burden Predicts for Early Death In Patients with AL Amyloidosis Blood. 116: 1893-1893. DOI: 10.1182/Blood.V116.21.1893.1893  0.117
2011 Rana V, Srivastava G, Hayman SR, Buadi FK, Gertz MA, Lacy MQ, Greipp PR, Zeldenrust SR, Dispenzieri A, Kyle RA, Lust JA, Short KD, Dingli D, Russell SJ, Rajkumar SV, et al. Factors Predicting Early Mortality in Patients with Newly Diagnosed Multiple Myeloma, Blood. 118: 3981-3981. DOI: 10.1182/Blood.V118.21.3981.3981  0.117
2012 Kumar SK, Hayman SR, Buadi FK, Roy V, Lacy MQ, Gertz MA, Allred J, Laumann KM, Bergsagel LP, Dingli D, Mikhael JR, Reeder CB, Stewart AK, Zeldenrust SR, Greipp PR, ... ... Russell SJ, et al. Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial. Blood. 119: 4860-7. PMID 22504925 DOI: 10.1182/Blood-2012-01-407791  0.116
2015 Kourelis T, Buadi F, Gertz MA, Kumar S, Lacy MQ, Kapoor P, Go RS, Lust JA, Hayman SR, Rajkumar SV, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Leung N, et al. Presentation and Outcomes of Localized Amyloidosis: The Mayo Clinic Experience Blood. 126: 4197-4197. DOI: 10.1182/Blood.V126.23.4197.4197  0.116
2017 Dispenzieri A, Tong C, LaPlant B, Lacy MQ, Laumann K, Dingli D, Zhou Y, Federspiel MJ, Gertz MA, Hayman S, Buadi F, O'Connor M, Lowe VJ, Peng KW, Russell SJ. Phase I trial of systemic administration of edmonston strain of measles virus, genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma. Leukemia. PMID 28439108 DOI: 10.1038/leu.2017.120  0.116
2008 Kumar S, Hayman S, Buadi F, Lacy M, Stewart K, Allred J, Lauman K, McCarty T, Bergsagel L, Dingli D, Fonseca R, Gertz M, Greipp P, Lust J, Russell S, et al. Phase II Trial of Lenalidomide (Revlimid™) with Cyclophosphamide and Dexamethasone (RCd) for Newly Diagnosed Myeloma Blood. 112: 91-91. DOI: 10.1182/Blood.V112.11.91.91  0.116
2017 Dingli D, Ailawadhi S, Bergsagel PL, Buadi FK, Dispenzieri A, Fonseca R, Gertz MA, Gonsalves WI, Hayman SR, Kapoor P, Kourelis T, Kumar SK, Kyle RA, Lacy MQ, Leung N, ... ... Russell SJ, et al. Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy. Mayo Clinic Proceedings. PMID 28291589 DOI: 10.1016/j.mayocp.2017.01.003  0.115
2016 Binder M, Rajkumar SV, Ketterling RP, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Hayman SR, Hwa YL, Zeldenrust SR, Lust JA, Russell SJ, Leung N, Kapoor P, Go RS, et al. Predicting Poor Overall Survival in Patients with Newly Diagnosed Multiple Myeloma and Standard-Risk Cytogenetics Treated with Novel Agents Blood. 128: 3255-3255. DOI: 10.1182/Blood.V128.22.3255.3255  0.115
2006 Dispenzieri A, Lacy MQ, Katzmann JA, Rajkumar SV, Abraham RS, Hayman SR, Kumar SK, Clark R, Kyle RA, Litzow MR, Inwards DJ, Ansell SM, Micallef IM, Porrata LF, Elliott MA, ... ... Russell SJ, et al. Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood. 107: 3378-83. PMID 16397135 DOI: 10.1182/Blood-2005-07-2922  0.115
2018 Binder M, Rajkumar SV, Lacy MQ, Gertz MA, Buadi FK, Dispenzieri A, Hwa L, Fonder A, Hobbs M, Hayman SR, Zeldenrust S, Lust JA, Russell SJ, Leung N, Kapoor P, et al. Prognostic Significance of Early Immune Reconstitution in Newly Diagnosed Multiple Myeloma Blood. 132: 3158-3158. DOI: 10.1182/Blood-2018-99-113970  0.115
2012 Lust JA, Usmani SZ, Hamadani M, Barranco C, Lacy MQ, Dispenzieri A, Gertz MA, Dingli D, Russell S, Buadi FK, Zeldenrust SR, Hayman SR, Rajkumar SV, Kumar SK, Thompson J, et al. Phase 1b/2a Open-Label, Multiple-Dose, Dose-Escalation Study to Evaluate the Safety and Tolerability of SNS01-T Administered by Intravenous Infusion in Patients with Relapsed or Refractory Multiple Myeloma. Blood. 120: 2973-2973. DOI: 10.1182/Blood.V120.21.2973.2973  0.115
2015 Galanis E, Atherton PJ, Maurer MJ, Knutson KL, Dowdy SC, Cliby WA, Haluska P, Long HJ, Oberg A, Aderca I, Block MS, Bakkum-Gamez J, Federspiel MJ, Russell SJ, Kalli KR, et al. Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer. Cancer Research. 75: 22-30. PMID 25398436 DOI: 10.1158/0008-5472.Can-14-2533  0.114
2009 Kumar SK, Mikhael JR, Buadi FK, Dingli D, Dispenzieri A, Fonseca R, Gertz MA, Greipp PR, Hayman SR, Kyle RA, Lacy MQ, Lust JA, Reeder CB, Roy V, Russell SJ, et al. Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines. Mayo Clinic Proceedings. 84: 1095-110. PMID 19955246 DOI: 10.4065/Mcp.2009.0603  0.114
2018 Muchtar E, Gertz MA, Lacy MQ, Dingli D, Buadi FK, Grogan M, abou Ezzeddine OF, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa Y, Gonsalves WI, Warsame R, ... ... Russell SJ, et al. Long-Term AL Amyloidosis Survivors Among Non-Selected Referral Population Blood. 132: 3226-3226. DOI: 10.1182/Blood-2018-99-117802  0.114
2013 Hwa YL, Laumann KM, LaPlant BR, Buadi F, Dingli D, Dispenzieri A, Gertz MA, Go RS, Hayman SR, Kapoor P, Kumar SK, Leung N, Lin Y, Lust JA, McCurdy A, ... ... Russell S, et al. Effect Of Immediate Prior-Line Lenalidomide Or Thalidomide Therapy On Response To Pomalidomide In Multiple Myeloma Blood. 122: 1979-1979. DOI: 10.1182/Blood.V122.21.1979.1979  0.114
2019 Russell L, Peng KW, Russell SJ, Diaz RM. Oncolytic Viruses: Priming Time for Cancer Immunotherapy. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. PMID 31321623 DOI: 10.1007/s40259-019-00367-0  0.114
2013 Singh PP, Gonsalves WI, Gupta V, Buadi F, Lacy M, Dispenzieri A, Gertz M, Hayman SR, Dingli D, Russell SJ, Lust JA, Zeldenrust SR, Kapoor P, McCurdy AR, Rajkumar SV, et al. Clinical outcomes after intensive VDT-PACE therapy for relapsed multiple myeloma. Journal of Clinical Oncology. 31: 8600-8600. DOI: 10.1200/Jco.2013.31.15_Suppl.8600  0.114
2012 Kapoor P, Gertz MA, Dispenzieri A, Lacy MQ, Dingli D, Hayman SR, Buadi FK, Russell S, Lin Y, Witzig TE, Lust JA, Zeldenrust SR, Greipp PR, Kyle RA, Rajkumar V, et al. Importance of Achieving Sustained Stringent Complete Response (sCR) Following Autologous Stem Cell Transplantation in Multiple Myeloma Blood. 120: 1988-1988. DOI: 10.1182/blood.v120.21.1988.1988  0.114
2019 Evans LA, Go RS, Nandakumar B, Buadi FK, Dispenzieri A, Dingli D, Lacy MQ, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs MA, Hwa YL, Muchtar E, Warsame RM, ... ... Russell SJ, et al. The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients with Newly Diagnosed Multiple Myeloma Blood. 134: 2197-2197. DOI: 10.1182/Blood-2019-128256  0.114
1995 Vile RG, Russell SJ. Retroviruses as vectors British Medical Bulletin. 51: 12-30. PMID 7767638 DOI: 10.1093/Oxfordjournals.Bmb.A072941  0.114
2012 Studebaker AW, Hutzen B, Pierson CR, Russell SJ, Galanis E, Raffel C. Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastoma. Neuro-Oncology. 14: 459-70. PMID 22307474 DOI: 10.1093/neuonc/nor231  0.114
2012 Dispenzieri A, Buadi F, Laumann K, LaPlant B, Hayman SR, Kumar SK, Dingli D, Zeldenrust SR, Mikhael JR, Hall R, Rajkumar SV, Reeder C, Fonseca R, Bergsagel PL, Stewart AK, ... ... Russell SJ, et al. Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis. Blood. 119: 5397-404. PMID 22493299 DOI: 10.1182/Blood-2012-02-413161  0.114
2010 Chee CE, Rajkumar V, Gertz M, Lacy M, Zeldenrust S, Kumar S, Hayman SR, Buadi F, Russell S, Kyle R, Greipp PR, Dispenzieri A. Unraveling Early Mortality In Patients with AL Amyloidosis Blood. 116: 4990-4990. DOI: 10.1182/blood.v116.21.4990.4990  0.113
2016 Tandon N, Sidana S, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Dingli D, Fonder A, Hobbs M, Hayman SR, Gonsalves WI, Hwa YL, Kapoor P, Kyle RA, Leung N, ... ... Russell SJ, et al. Treatment Patterns and Outcomes Following Initial Relapse in Patients with Relapsed Systemic Immunoglobulin Light Chain Amyloidosis Blood. 128: 3338-3338. DOI: 10.1182/Blood.V128.22.3338.3338  0.113
2006 Hayman S, Gertz M, Lacy M, Dispenzieri A, Fonseca R, Geyer S, Kumar S, Zeldenrust S, Russell S, Lust J, Kyle R, Greipp P, Witzig T, Rajkumar SV. Long-Term Results of Single-Agent Thalidomide as Initial Therapy for Asymptomatic (Smoldering or Indolent) Myeloma. Blood. 108: 3568-3568. DOI: 10.1182/Blood.V108.11.3568.3568  0.113
2018 Lakshman A, Painuly U, Rajkumar SV, Ketterling RP, Kapoor P, Greipp P, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Dispenzieri A, Fonder A, Hayman SR, Hobbs M, Gonsalves WI, ... ... Russell SJ, et al. Impact of Acquired Del(17p) in Patients with Multiple Myeloma Blood. 132: 4449-4449. DOI: 10.1182/Blood-2018-99-115458  0.113
2011 Mikhael JR, Hayman SR, Laumann K, Roy V, LaPlant BR, Kumar S, Buadi FK, Reeder CB, Gertz MA, Dispenzieri A, Lust JA, Stewart AK, Russell S, Bergsagel P, Dingli D, et al. Long Term Outcomes of Pomalidomide and Dexamethasone in Patients with Relapsed Multiple Myeloma: Analysis 4 Years After the Original Cohort Blood. 118: 2942-2942. DOI: 10.1182/Blood.V118.21.2942.2942  0.112
2019 Buadi FK, Lacy MQ, Laplant B, Wolfe E, Gertz MA, Ailawadhi S, Hayman SR, Go RS, Helgeson DK, Roy V, Reeder CB, Fonder A, Hwa YL, Hobbs MA, Bergsagel PL, ... ... Russell SJ, et al. Phase 2 Trial of Ixazomib, Cyclophosphamide and Dexamethasone in Relapsed Multiple Myeloma Blood. 134: 1904-1904. DOI: 10.1182/Blood-2019-131478  0.112
1990 Russell SJ. Lymphokine gene therapy for cancer. Immunology Today. 11: 196-200. PMID 2191681 DOI: 10.1016/0167-5699(90)90081-J  0.112
2017 Muchtar E, Dispenzieri A, Lacy MQ, Leung N, Buadi FK, Grogan M, Hayman SR, Kapoor P, Hwa YL, Fonder A, Hobbs M, Chakraborty R, Gonsalves WI, Kourelis T, Warsame R, ... Russell SJ, et al. Depth of Organ Response in Newly Diagnosed AL Amyloidosis Is Associated with Improved Survival: Improved Outcome Discrimination with Graded Organ Response Blood. 130: 3154-3154. DOI: 10.1182/Blood.V130.Suppl_1.3154.3154  0.112
2012 Srivastava G, Rana V, Lacy M, Gertz MA, Dispenzieri A, Hayman SR, Buadi F, Dingli D, Lust JA, Zeldenrust SR, Russell SJ, Rajkumar V, Kumar S. Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma. Journal of Clinical Oncology. 30: 8096-8096. DOI: 10.1200/JCO.2012.30.15_SUPPL.8096  0.112
2015 Dispenzieri A, Buadi F, Kumar SK, Reeder CB, Sher T, Lacy MQ, Kyle RA, Mikhael JR, Roy V, Leung N, Grogan M, Kapoor P, Lust JA, Dingli D, Go RS, ... ... Russell SJ, et al. Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement. Mayo Clinic Proceedings. 90: 1054-81. PMID 26250727 DOI: 10.1016/j.mayocp.2015.06.009  0.112
2018 Sterner RM, Sakemura R, Yang N, Cox MJ, Khadka RH, Forsman CL, Hansen MJ, Jin F, Ayasoufi K, Hefazi M, Welch BM, Schick KJ, Walters DK, Martinez G, Ahmed O, ... ... Russell SJ, et al. GM-CSF Blockade during Chimeric Antigen Receptor T Cell Therapy Reduces Cytokine Release Syndrome and Neurotoxicity and May Enhance Their Effector Functions Blood. 132: 961-961. DOI: 10.1182/Blood-2018-99-111766  0.112
2009 Siragusa S, Morice W, Gertz MA, Kyle R, Greipp PR, Lust JA, Witzig TE, Lacy MQ, Zeldenrust SR, Rajkumar SV, Hayman SR, Buadi F, Russell SJ, Kumar S, Dingli D, et al. Asymptomatic Amyloidosis at the Time of Diagnostic Bone Marrow Biopsy in Newly Diagnosed Patients with Multiple Myeloma and Smoldering Multiple Myeloma. Blood. 114: 2803-2803. DOI: 10.1182/Blood.V114.22.2803.2803  0.112
2014 Russell SJ, Federspiel MJ, Peng KW, Tong C, Dingli D, Morice WG, Lowe V, O'Connor MK, Kyle RA, Leung N, Buadi FK, Rajkumar SV, Gertz MA, Lacy MQ, Dispenzieri A. Remission of disseminated cancer after systemic oncolytic virotherapy. Mayo Clinic Proceedings. 89: 926-33. PMID 24835528 DOI: 10.1016/j.mayocp.2014.04.003  0.112
2021 Cook J, Peng KW, Geyer SM, Ginos BF, Dueck AC, Packiriswamy N, Zhang L, Brunton B, Balakrishnan B, Witzig TE, Broski SM, Patnaik M, Buadi F, Dispenzieri A, Gertz MA, ... ... Russell SJ, et al. Clinical activity of systemic VSV-IFNβ-NIS oncolytic virotherapy in patients with relapsed refractory T-cell lymphoma. Journal of Clinical Oncology. 39: 2500-2500. DOI: 10.1200/JCO.2021.39.15_SUPPL.2500  0.112
2017 Sidana S, Tandon N, Dispenzieri A, Gertz MA, Buadi F, Lacy M, Dingli D, Fonder AL, Hayman SR, Hobbs MA, Hwa YL, Kapoor P, Kyle RA, Leung N, Go RS, ... ... Russell SJ, et al. Risk stratification by detection of clonal circulating plasma cells (CPCs) by multi-parametric flow cytometry (MFC) in light chain amyloidosis (AL). Journal of Clinical Oncology. 35: 8047-8047. DOI: 10.1200/Jco.2017.35.15_Suppl.8047  0.111
2012 Lust JA, Barranco C, Lacy M, Dispenzieri A, Gertz MA, Dingli D, Russell SJ, Buadi F, Zeldenrust SR, Hayman SR, Rajkumar SV, Kumar S, Usmani SZ, Thompson J, Taylor C, et al. Phase I/II open-label, multiple-dose, dose-escalation study to evaluate the safety and tolerability of SNS01T administered by intravenous infusion in patients with relapsed or refractory multiple myeloma. Journal of Clinical Oncology. 30: TPS8116-TPS8116. DOI: 10.1200/jco.2012.30.15_suppl.tps8116  0.111
2010 Detweiler-Short K, Hayman S, Gertz MA, Lacy MQ, Dispenzieri A, Kumar S, Zeldenrust SR, Russell SJ, Lust JA, Kyle RA, Greipp PR, Witzig TE, Vincent Rajkumar S. Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma. American Journal of Hematology. 85: 737-40. PMID 20730790 DOI: 10.1002/Ajh.21821  0.111
2021 Evans LA, Go R, Warsame R, Nandakumar B, Buadi FK, Dispenzieri A, Dingli D, Lacy MQ, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Muchtar E, ... ... Russell S, et al. The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Cross-analysis of a Population-based Registry and a Tertiary Care Center. Clinical Lymphoma, Myeloma & Leukemia. PMID 33785296 DOI: 10.1016/j.clml.2021.02.001  0.111
2018 Binder M, Rajkumar SV, Lacy MQ, Gertz MA, Buadi FK, Dispenzieri A, Hwa L, Fonder A, Hobbs M, Hayman SR, Zeldenrust S, Lust JA, Russell SJ, Leung N, Kapoor P, et al. Early Prediction of Treatment Response in Newly Diagnosed Multiple Myeloma Blood. 132: 3159-3159. DOI: 10.1182/Blood-2018-99-111624  0.111
2003 Sandrin V, Russell SJ, Cosset FL. Targeting retroviral and lentiviral vectors. Current Topics in Microbiology and Immunology. 281: 137-78. PMID 12932077 DOI: 10.1007/978-3-642-19012-4_4  0.111
2013 Donnelly OG, Errington-Mais F, Steele L, Hadac E, Jennings V, Scott K, Peach H, Phillips RM, Bond J, Pandha H, Harrington K, Vile R, Russell S, Selby P, Melcher AA. Measles virus causes immunogenic cell death in human melanoma. Gene Therapy. 20: 7-15. PMID 22170342 DOI: 10.1038/Gt.2011.205  0.11
2007 Tan T, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Zeldenrust SR, Lust JA, Russell SJ, Dingli D, Greipp PR, Kyle RA, Rajkumar SV, Gertz MA, Kumar S. Melphalan and Dexamethasone Is an Effective Therapy for Primary Systemic Amyloidosis. Blood. 110: 3608-3608. DOI: 10.1182/Blood.V110.11.3608.3608  0.11
2018 Muchtar E, Dispenzieri A, Leung N, Buadi FK, Dingli D, Hayman SR, Kapoor P, Hwa YL, Fonder A, Hobbs M, Gonsalves WI, Kourelis T, Warsame R, Russell SJ, Lust JA, et al. Optimizing Deep Response Assessment for AL Amyloidosis Using Involved Free Light Chain Level at End of Therapy Blood. 132: 3227-3227. DOI: 10.1182/Blood-2018-99-113958  0.11
2016 Hwa YL, Shi Q, Kumar S, Lacy MQ, Gertz MA, Kapoor P, Buadi FK, Leung N, Dingli D, Go RS, Hayman SR, Gonsalves WI, Russell SJ, Lust JA, Lin Y, et al. Beta-Blockers Improved Survival Outcomes in Patients with Multiple Myeloma: A Retrospective Evaluation Blood. 128: 3306-3306. DOI: 10.1182/Blood.V128.22.3306.3306  0.11
2013 Mikhael JR, Roy V, Richardson PG, Jakubowiak A, Laumann K, LaPlant BR, Dispenzieri A, Rajkumar SV, Fonseca R, Leung N, Buadi F, Bergsagel PL, Kyle R, Macp, Witzig TE, ... ... Russell S, et al. A Phase I/II Trial Of Pomalidomide, Bortezomib and Dexamethasone In Patients With Relpased Or Refractory Multiple Myeloma Blood. 122: 1940-1940. DOI: 10.1182/Blood.V122.21.1940.1940  0.11
2006 Lacy MQ, Dispenzieri A, Gertz MA, Greipp PR, Gollbach KL, Hayman SR, Kumar S, Lust JA, Rajkumar SV, Russell SJ, Witzig TE, Zeldenrust SR, Dingli D, Bergsagel PL, Fonseca R, et al. Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma. Mayo Clinic Proceedings. 81: 1047-53. PMID 16901028 DOI: 10.4065/81.8.1047  0.11
2012 Naik S, Nace R, Federspiel MJ, Barber GN, Peng KW, Russell SJ. Curative one-shot systemic virotherapy in murine myeloma Leukemia. 26: 1870-1878. PMID 22425894 DOI: 10.1038/Leu.2012.70  0.11
2019 Cripe TP, Bakkum-Gamez J, Merchan JR, Lacy MQ, Patel MR, Powell S, Strauss J, Zhang L, Sakuma T, Diaz M, Packiriswamy N, Upreti D, Brunton B, Jevremovic D, Russell SJ, et al. Abstract CT090: Rational design of an oncolytic virus permits use of interferon beta as a pharmacodynamic marker for clinical application Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-Ct090  0.11
2010 Galanis E, Hartmann LC, Cliby WA, Long HJ, Peethambaram PP, Barrette BA, Kaur JS, Haluska PJ, Aderca I, Zollman PJ, Sloan JA, Keeney G, Atherton PJ, Podratz KC, Dowdy SC, ... ... Russell SJ, et al. Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. Cancer Research. 70: 875-82. PMID 20103634 DOI: 10.1158/0008-5472.CAN-09-2762  0.11
2009 Naik S, Nace RA, Hadac EA, Dingli D, Federspiel M, Barber GN, Russell SJ. Engineering VSV-IFN-NIS for the Treatment of Multiple Myeloma. Blood. 114: 378-378. DOI: 10.1182/Blood.V114.22.378.378  0.109
2013 Saenger AK, Kumar SK, Gertz MA, Lacy MQ, Buadi F, Hayman SR, Leung N, Zeldenrust SR, McCurdy A, Kyle R, Dingli D, Kapoor P, Lin Y, Russell SJ, Go RS, et al. Soluble ST2 (sST2) Is a Novel Valuable Prognostic Marker Among Patients With Immunoglobulin Light Chain (AL) Amyloidosis Blood. 122: 3095-3095. DOI: 10.1182/Blood.V122.21.3095.3095  0.109
2016 Lee MC, Sulmasy DP, Gallo J, Kub J, Hughes MT, Russell S, Kellogg A, Owens SG, Terry P, Nolan MT. Decision-Making of Patients With Implantable Cardioverter-Defibrillators at End of Life: Family Members' Experiences. The American Journal of Hospice & Palliative Care. PMID 27034436 DOI: 10.1177/1049909116641622  0.109
2017 Velazquez-Salinas L, Naik S, Pauszek S, Peng KW, Russell SJ, Rodriguez L. Oncolytic Recombinant Vesicular stomatitis virus (VSV) is nonpathogenic and non-transmissible in pigs, a natural host of VSV. Human Gene Therapy. Clinical Development. PMID 28514874 DOI: 10.1089/humc.2017.015  0.109
2020 Bah ES, Nace RA, Peng KW, Muñoz-Alía MÁ, Russell SJ. Retargeted and Stealth Modified Oncolytic Measles Viruses for Systemic Cancer Therapy in Measles-Immune Patients. Molecular Cancer Therapeutics. PMID 32847970 DOI: 10.1158/1535-7163.MCT-20-0134  0.108
2005 Nakamura T, Russell SJ. Oncolytic measles viruses for cancer therapy. Expert Opinion On Biological Therapy. 4: 1685-92. PMID 15461580 DOI: 10.1517/14712598.4.10.1685  0.108
2010 Lacy MQ, Hayman SR, Gertz MA, Short KD, Dispenzieri A, Kumar S, Greipp PR, Lust JA, Russell SJ, Dingli D, Zeldenrust S, Fonseca R, Bergsagel PL, Roy V, Mikhael JR, et al. Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM). Leukemia. 24: 1934-9. PMID 20827286 DOI: 10.1182/Blood.V114.22.429.429  0.108
2017 Rosenthal A, Dueck AC, Ansell S, Gano K, Conley C, Nowakowski GS, Camoriano J, Leis JF, Mikhael JR, Stewart AK, Inwards D, Dingli D, Kumar S, Noel P, Gertz M, ... ... Russell S, et al. A Phase 2 study of Lenalidomide, Rituximab, Cyclophosphamide and Dexamethasone (LR-CD) for Untreated Low Grade Non-Hodgkin Lymphoma Requiring Therapy. American Journal of Hematology. PMID 28230270 DOI: 10.1002/ajh.24693  0.108
2013 Mikhael JR, Dingli D, Roy V, Reeder CB, Buadi FK, Hayman SR, Dispenzieri A, Fonseca R, Sher T, Kyle RA, Lin Y, Russell SJ, Kumar S, Bergsagel PL, Zeldenrust SR, et al. Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013. Mayo Clinic Proceedings. 88: 360-76. PMID 23541011 DOI: 10.1016/j.mayocp.2013.01.019  0.108
2006 Lacy M, Gertz M, Dispenzieri A, Hayman S, Geyer S, Zeldenrust S, Kumar S, Greipp P, Fonseca R, Lust J, Russell S, Kyle R, Witzig T, Bergsagel L, Rajkumar SV. Lenalidomide Plus Dexamethasone (Rev/Dex) in Newly Diagnosed Myeloma: Response to Therapy, Time to Progression, and Survival. Blood. 108: 798-798. DOI: 10.1182/Blood.V108.11.798.798  0.108
2003 Dingli D, Diaz RM, Bergert ER, O'Connor MK, Morris JC, Russell SJ. Genetically targeted radiotherapy for multiple myeloma. Blood. 102: 489-96. PMID 12649158 DOI: 10.1182/Blood-2002-11-3390  0.108
2017 Lakshman A, Abeykoon JP, Kumar SK, Rajkumar SV, Dingli D, Buadi FK, Gonsalves WI, Leung N, Dispenzieri A, Kourelis TV, Go RS, Lacy MQ, Hobbs MA, Lin Y, Warsame R, ... ... Russell SJ, et al. Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials. American Journal of Hematology. PMID 28799231 DOI: 10.1002/Ajh.24883  0.107
2013 Tesfay MZ, Kirk AC, Hadac EM, Griesmann GE, Federspiel MJ, Barber GN, Henry SM, Peng KW, Russell SJ. PEGylation of vesicular stomatitis virus extends virus persistence in blood circulation of passively immunized mice. Journal of Virology. 87: 3752-9. PMID 23325695 DOI: 10.1128/Jvi.02832-12  0.107
2012 Warsame R, Bang S, Kumar SK, Lacy MQ, Buadi FK, Dingli D, Hayman SR, Lust JA, Russell S, Witzig TE, Kyle RA, Leung N, Zeldenrust SR, Rajkumar SV, Gertz MA, et al. Outcomes and Treatments of Relapsed AL Amyloidosis Following Stem Cell Transplant Blood. 120: 1858-1858. DOI: 10.1182/Blood.V120.21.1858.1858  0.107
2019 Muchtar E, Gertz MA, Lacy MQ, Go RS, Buadi FK, Dingli D, Grogan M, AbouEzzeddine OF, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Gonsalves W, ... ... Russell S, et al. Ten-year survivors in AL amyloidosis: characteristics and treatment pattern. British Journal of Haematology. PMID 31298751 DOI: 10.1111/Bjh.16096  0.107
2007 Kumar S, Hayman SR, Buadi FK, Lacy MQ, Stewart K, Greipp PR, Russell S, Zeldenrust S, Gertz MA, Bergsagel L, Fonseca R, Allred J, Campbell M, Lust JA, Witzig TE, et al. Phase II Trial of Lenalidomide, Cyclophosphamide, and Dexamethasone (CRd) for Newly Diagnosed Myeloma. Blood. 110: 190-190. DOI: 10.1182/Blood.V110.11.190.190  0.107
2019 Sakemura R, Suksanpaisan L, Khadka RH, Newsom AN, Hansen MJ, Cox MJ, Hefazi M, Manriquez Roman C, Schick KJ, Tapper EE, Roman Moreno P, Ruff MW, Parikh SA, Kay NE, Peng K, ... Russell SJ, et al. Development of a Sensitive and Efficient Reporter Platform for the Detection of Chimeric Antigen Receptor T Cell Expansion, Trafficking, and Toxicity Blood. 134: 53-53. DOI: 10.1182/blood-2019-123476  0.106
2020 Paquin A, Visram A, Kumar SK, Gertz MA, Cantwell H, Buadi FK, Lacy MQ, Dispenzieri A, Dingli D, Hwa L, Fonder A, Hobbs M, Hayman SR, Lust JA, Russell SJ, et al. Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma. Blood Cancer Journal. 10: 87. PMID 32859899 DOI: 10.1038/S41408-020-00353-8  0.106
2015 Hwa YL, Kumar SK, Lacy MQ, Gertz MA, Buadi F, Rajkumar SV, Go RS, Leung N, Kapoor P, Dingli D, Russell SJ, Lust JA, Hayman SR, Kourelis T, Dispenzieri A. Impact of Bone Marrow Plasmacytosis on Outcome in Patients with AL Amyloidosis Following Autologous Stem Cell Transplant Blood. 126: 3177-3177. DOI: 10.1182/Blood.V126.23.3177.3177  0.106
2007 Goel A, Carlson SK, Classic KL, Greiner S, Naik S, Power AT, Bell JC, Russell SJ. Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene. Blood. 110: 2342-50. PMID 17515401 DOI: 10.1182/Blood-2007-01-065573  0.106
2014 Tesfay MZ, Ammayappan A, Federspiel MJ, Barber GN, Stojdl D, Peng KW, Russell SJ. Vesiculovirus neutralization by natural IgM and complement. Journal of Virology. 88: 6148-57. PMID 24648451 DOI: 10.1128/Jvi.00074-14  0.106
2014 Miller A, Suksanpaisan L, Naik S, Nace R, Federspiel M, Peng KW, Russell SJ. Reporter gene imaging identifies intratumoral infection voids as a critical barrier to systemic oncolytic virus efficacy. Molecular Therapy Oncolytics. 1: 14005. PMID 27119095 DOI: 10.1038/mto.2014.5  0.106
2020 Warsame R, LaPlant B, Kumar SK, Laumann K, Perez Burbano G, Buadi FK, Gertz MA, Kyle RA, Lacy MQ, Dingli D, Leung N, Hayman SR, Kapoor P, Hwa YL, Fonder A, ... ... Russell SJ, et al. Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis. Blood Cancer Journal. 10: 4. PMID 31913261 DOI: 10.1038/S41408-019-0266-9  0.106
2016 Hwa YL, Warsame R, Gertz MA, Buadi FK, Lacy MQ, Kumar S, Dingli D, Zeldenrust SR, Leung N, Hayman SR, Kapoor P, Gonsalves WI, Kourelis T, Russell SJ, Go RS, et al. Practice Patterns of Re-Initiation of Therapy at Time of Relapse or Progression Post- Autologous Stem Cell Transplant (ASCT) Among Patients with AL Amyloidosis Blood. 128: 3444-3444. DOI: 10.1182/Blood.V128.22.3444.3444  0.106
2008 Munguia A, Ota T, Miest T, Russell SJ. Cell carriers to deliver oncolytic viruses to sites of myeloma tumor growth. Gene Therapy. 15: 797-806. PMID 18356812 DOI: 10.1038/gt.2008.45  0.106
2013 Liu C, Suksanpaisan L, Chen YW, Russell SJ, Peng KW. Enhancing cytokine-induced killer cell therapy of multiple myeloma. Experimental Hematology. 41: 508-17. PMID 23403007 DOI: 10.1016/j.exphem.2013.01.010  0.106
2018 Sidana S, Tandon N, Dispenzieri A, Gertz MA, Dingli D, Jevremovic D, Morice WG, Kapoor P, Kourelis TV, Lacy MQ, Hayman SR, Buadi FK, Leung N, Go RS, Lin Y, ... Russell SJ, et al. Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis. Leukemia. PMID 29483709 DOI: 10.1038/S41375-018-0063-7  0.106
2016 Gonsalves WI, Rajkumar SV, Timm M, Morice W, Dispenzieri A, Lacy M, Buadi F, Dingli D, Go RS, Leung N, Kapoor P, Hayman SR, Lust JA, Russell S, Zeldenrust SR, et al. Quantification of circulating clonal plasma cells (cPCs) via multiparametric flow cytometry (MFC) to identify patients with smoldering multiple myeloma (SMM) at high risk of progression. Journal of Clinical Oncology. 34: 8015-8015. DOI: 10.1200/Jco.2016.34.15_Suppl.8015  0.105
2019 Malave GC, Kapoor P, Dispenzieri A, Gertz MA, Lacy MQ, Hayman SR, Dingli D, Buadi FK, Muchtar E, Gonsalves WI, Leung N, Go RS, Siddiqui M, Kourelis T, Warsame RM, ... ... Russell SJ, et al. Determinants of Clinical Trial Participation and Impact on Survival Outcomes Among Patients with Newly Diagnosed Multiple Myeloma Blood. 134: 5833-5833. DOI: 10.1182/Blood-2019-131776  0.105
2014 Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, Kapoor P, Dingli D, Hayman SR, Leung N, Lust J, McCurdy A, Russell SJ, Zeldenrust SR, Kyle RA, et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia. 28: 1122-8. PMID 24157580 DOI: 10.1038/Leu.2013.313  0.105
2013 Kourelis T, Kumar SK, Srivastava G, Gertz MA, Lacy MQ, Buadi FK, Hayman SR, Zeldenrust SR, Leung N, Kyle R, Russell S, Dingli D, Lust JA, Lin Y, Kapoor P, et al. Long Term Response To Lenalidomide With and Without Continuous Therapy Among Patients With Newly Diagnosed Multiple Myeloma Blood. 122: 3209-3209. DOI: 10.1182/blood.v122.21.3209.3209  0.105
2007 Kumar S, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Zeldenrust SR, Dingli D, Russell S, Lust JA, Greipp PR, Kyle RA, Gertz MA. Improving Survival in Multiple Myeloma: Impact of Novel Therapies. Blood. 110: 3594-3594. DOI: 10.1182/Blood.V110.11.3594.3594  0.105
2015 Miller A, Russell SJ. The use of the NIS reporter gene for optimizing oncolytic virotherapy. Expert Opinion On Biological Therapy. 1-18. PMID 26457362 DOI: 10.1517/14712598.2016.1100162  0.104
2013 Yarde DN, Naik S, Nace RA, Peng KW, Federspiel MJ, Russell SJ. Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV. Cancer Gene Therapy. 20: 616-21. PMID 24176894 DOI: 10.1038/cgt.2013.63  0.104
2008 Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Zeldenrust SR, Dingli D, Russell SJ, Lust JA, Greipp PR, Kyle RA, Gertz MA. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 111: 2516-20. PMID 17975015 DOI: 10.1182/Blood-2007-10-116129  0.104
2017 Paquin A, Kumar SK, Buadi FK, Gertz MA, Lacy MQ, Dispenzieri A, Dingli D, Hwa L, Fonder A, Hobbs M, Hayman SR, Zeldenrust S, Lust JA, Russell SJ, Leung N, et al. Overall Survival of Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma: Comparative Effectiveness Analysis of Modern Induction Regimens on Outcome Blood. 130: 3138-3138. DOI: 10.1182/Blood.V130.Suppl_1.3138.3138  0.104
2001 Peng KW, Ahmann GJ, Pham L, Greipp PR, Cattaneo R, Russell SJ. Systemic therapy of myeloma xenografts by an attenuated measles virus. Blood. 98: 2002-7. PMID 11567982 DOI: 10.1182/blood.V98.7.2002  0.104
2017 Lakshman A, Singh PP, Rajkumar SV, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Dingli D, Hwa YL, Fonder AL, Hobbs M, Hayman SR, Zeldenrust SR, Lust JA, Russell SJ, et al. Efficacy of VDT PACE-like Regimens in Treatment of Relapsed/Refractory Multiple Myeloma. American Journal of Hematology. PMID 29067723 DOI: 10.1002/Ajh.24954  0.104
2006 Goel A, Dispenzieri A, Witzig TE, Russell SJ. Enhancing the therapeutic index of radiation in multiple myeloma Drug Discovery Today: Disease Mechanisms. 3: 515-522. DOI: 10.1016/J.Ddmec.2006.11.012  0.104
2015 Dispenzieri A, Gertz MA, Saenger A, Kumar SK, Lacy MQ, Buadi FK, Dingli D, Leung N, Zeldenrust S, Hayman SR, Kapoor P, Grogan M, Hwa L, Russell SJ, Go RS, et al. Soluble suppression of tumorigenicity 2 (sST2), but not galactin-3, adds to prognostication in patients with systemic AL amyloidosis independent of NT-proBNP and troponin T. American Journal of Hematology. 90: 524-8. PMID 25753178 DOI: 10.1002/Ajh.24001  0.104
2009 Dingli D, Offord C, Myers R, Peng KW, Carr TW, Josic K, Russell SJ, Bajzer Z. Dynamics of multiple myeloma tumor therapy with a recombinant measles virus. Cancer Gene Therapy. 16: 873-82. PMID 19498461 DOI: 10.1038/cgt.2009.40  0.104
2013 Yarde DN, Nace RA, Russell SJ. Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells in vitro but have additive anti-myeloma activity in vivo. Experimental Hematology. 41: 1038-49. PMID 24067362 DOI: 10.1016/j.exphem.2013.09.005  0.104
2012 Li H, Peng KW, Russell SJ. Oncolytic measles virus encoding thyroidal sodium iodide symporter for squamous cell cancer of the head and neck radiovirotherapy. Human Gene Therapy. 23: 295-301. PMID 22235810 DOI: 10.1089/hum.2011.128  0.103
2017 Muchtar E, Gertz MA, Kumar SK, Lacy MQ, Dingli D, Buadi FK, Grogan M, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Gonsalves W, Warsame R, ... ... Russell S, et al. Improved outcomes for newly diagnosed AL amyloidosis over the years 2000-2014: cracking the glass ceiling of early death. Blood. PMID 28126928 DOI: 10.1182/Blood-2016-11-751628  0.103
2004 Dingli D, Peng KW, Harvey ME, Greipp PR, O'Connor MK, Cattaneo R, Morris JC, Russell SJ. Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter. Blood. 103: 1641-6. PMID 14604966 DOI: 10.1182/Blood-2003-07-2233  0.103
2008 Blechacz B, Russell SJ. Measles virus as an oncolytic vector platform. Current Gene Therapy. 8: 162-75. PMID 18537591 DOI: 10.2174/156652308784746459  0.103
2016 Sidana S, Tandon N, Dispenzieri A, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Fonder A, Hayman SR, Hobbs M, Gonsalves WI, Hwa YL, Kapoor P, Kyle RA, Leung N, ... ... Russell SJ, et al. Clinical Presentation and Outcomes of Patients with Light Chain Amyloidosis Who Have Non-Evaluable Free Light Chains at Diagnosis Blood. 128: 3272-3272. DOI: 10.1182/Blood.V128.22.3272.3272  0.103
2020 Merchan JR, Patel M, Cripe TP, Old MO, Strauss JF, Thomassen A, Diaz RM, Peng KW, Russell SJ, Russell L, Reckner M, Wiegert E, Bexon AS, Powell SF. Relationship of infusion duration to safety, efficacy, and pharmacodynamics (PD): Second part of a phase I-II study using VSV-IFNβ-NIS (VV1) oncolytic virus in patients with refractory solid tumors. Journal of Clinical Oncology. 38: 3090-3090. DOI: 10.1200/jco.2020.38.15_suppl.3090  0.103
2011 Liu YP, Tong C, Dispenzieri A, Federspiel MJ, Russell SJ, Peng KW. Polyinosinic acid decreases sequestration and improves systemic therapy of measles virus. Cancer Gene Therapy. 19: 202-11. PMID 22116376 DOI: 10.1038/cgt.2011.82  0.103
2010 Dispenzieri A, Gertz MAA, Hayman SR, Buadi F, Kumar S, Reeder CB, Mikhael JR, Zeldenrust S, Rajkumar SV, Detweiler-Short K, Greipp PR, Russell SJ, Dingli D, Allred J, Laumann K, et al. A Phase-2 Study of Pomalidomide and Dexamethasone In Previously-Treated Light-Chain (AL) Amyloidosis Blood. 116: 987-987. DOI: 10.1182/Blood.V116.21.987.987  0.103
2018 Powell S, Patel MR, Merchan JR, Cripe TP, Strauss J, Diaz RM, Packiriswamy N, Brunton BA, Upreti D, Khan R, Suksanpaisan L, Vandergaast R, Russell SJ, Bexon AS, Peng KW. Abstract CT051: Preliminary correlative and clinical data from a first-in-human (FIH) study of the intratumoral (IT) oncolytic virotherapy, Voyager-V1, in patients with solid tumors Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Ct051  0.103
2009 Dingli D, Gay F, Buadi F, Dispenzieri A, Hayman SR, Kumar S, Lacy MQ, Russell SJ, Rajkumar V, Gertz M. Depth of Response with Stem Cell Transplantation and Outcome for Multiple Myeloma in the Era of Novel Agents. Blood. 114: 1228-1228. DOI: 10.1182/BLOOD.V114.22.1228.1228  0.102
2018 Dispenzieri A, Dasari S, Arendt BK, Kohlhagen MK, Kourelis T, Gertz MA, Kumar SK, Rajkumar SV, Buadi FK, Dingli D, Leung N, Kapoor P, Go RS, Kyle RA, Muchtar E, ... ... Russell SJ, et al. Mass Spectrometry to Measure Response in Immunoglobulin Light Chain Amyloidosis (AL) Blood. 132: 4502-4502. DOI: 10.1182/Blood-2018-99-119969  0.102
2019 Lakshman A, Painuly U, Rajkumar SV, Ketterling RP, Kapoor P, Greipp PT, Dispenzieri A, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, ... ... Russell SJ, et al. Impact of acquired del(17p) in multiple myeloma. Blood Advances. 3: 1930-1938. PMID 31248884 DOI: 10.1182/Bloodadvances.2018028530  0.102
2020 Packiriswamy N, Upreti D, Zhou Y, Khan R, Miller A, Diaz RM, Rooney CM, Dispenzieri A, Peng KW, Russell SJ. Oncolytic measles virus therapy enhances tumor antigen-specific T-cell responses in patients with multiple myeloma. Leukemia. PMID 32327728 DOI: 10.1038/S41375-020-0828-7  0.102
2016 Ammayappan A, Russell SJ, Federspiel MJ. Recombinant mumps virus as a cancer therapeutic agent. Molecular Therapy Oncolytics. 3: 16019. PMID 27556105 DOI: 10.1038/mto.2016.19  0.102
2007 Kelly E, Russell SJ. History of oncolytic viruses: genesis to genetic engineering. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 651-9. PMID 17299401 DOI: 10.1038/SJ.MT.6300108  0.102
2017 Ghosh T, Gonsalves WI, Jevremovic D, Dispenzieri A, Dingli D, Timm MM, Morice WG, Kapoor P, Kourelis TV, Lacy MQ, Hayman SR, Buadi FK, Leung N, Go RS, Lin Y, ... Russell SJ, et al. The Prognostic Significance of Polyclonal Bone Marrow Plasma Cells in Patients with Relapsing Multiple Myeloma. American Journal of Hematology. PMID 28568244 DOI: 10.1002/Ajh.24807  0.101
2013 Li H, Nakashima H, Decklever TD, Nace RA, Russell SJ. HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy. Cancer Gene Therapy. 20: 478-85. PMID 23868101 DOI: 10.1038/cgt.2013.43  0.101
2012 Russell SJ, Peng KW, Bell JC. Oncolytic virotherapy Nature Biotechnology. 30: 658-670. PMID 22781695 DOI: 10.1038/nbt.2287  0.101
2006 Peng KW, Hadac EM, Anderson BD, Myers R, Harvey M, Greiner SM, Soeffker D, Federspiel MJ, Russell SJ. Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft model. Cancer Gene Therapy. 13: 732-8. PMID 16543921 DOI: 10.1038/sj.cgt.7700948  0.101
2000 Diaz RM, Bateman A, Emiliusen L, Fielding A, Trono D, Russell SJ, Vile RG. A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy. Gene Therapy. 7: 1656-63. PMID 11083474 DOI: 10.1038/Sj.Gt.3301277  0.101
2014 Kourelis TV, Kumar SK, Srivastava G, Gertz MA, Lacy MQ, Buadi FK, Hayman SR, Zeldenrust SR, Leung N, Kyle RA, Russell SJ, Dingli D, Lust JA, Lin Y, Kapoor P, et al. Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy. American Journal of Hematology. 89: 302-5. PMID 24265187 DOI: 10.1002/Ajh.23634  0.101
2020 Abdallah N, Sidana S, Dispenzieri A, Lacy M, Buadi F, Hayman S, Kapoor P, Leung N, Dingli D, Hwa YL, Lust J, Russell S, Gonsalves W, Go R, Hogan W, et al. Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosis. Bone Marrow Transplantation. PMID 32518290 DOI: 10.1038/S41409-020-0964-8  0.101
2009 Iankov ID, Hillestad ML, Dietz AB, Russell SJ, Galanis E. Converting tumor-specific markers into reporters of oncolytic virus infection. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1395-403. PMID 19471250 DOI: 10.1038/Mt.2009.92  0.1
2019 Gonsalves WI, Jevremovic D, Dispenzieri A, Buadi F, Dingli D, Lacy M, Kapoor P, Lin Y, Kourelis T, Muchtar E, Lust JA, Russell SJ, Go RS, Hayman SR, Leung N, et al. Upstaging the R-ISS classification of newly diagnosed multiple myeloma (NDMM) patients (pts) by quantifying circulating clonal plasma cells (cPCs) via multiparametric flow cytometry (MFC). Journal of Clinical Oncology. 37: 8031-8031. DOI: 10.1200/Jco.2019.37.15_Suppl.8031  0.1
2000 Russell SJ, Cosset FL. Modifying the host range properties of retroviral vectors. The Journal of Gene Medicine. 1: 300-11. PMID 10738547 DOI: 10.1002/(SICI)1521-2254(199909/10)1:5<300::AID-JGM59>3.0.CO;2-T  0.1
2000 Vile RG, Russell SJ, Lemoine NR. Cancer gene therapy: hard lessons and new courses. Gene Therapy. 7: 2-8. PMID 10680008 DOI: 10.1038/Sj.Gt.3301084  0.1
2008 Kapoor P, Kumar S, Fonseca R, Lacy MQ, Witzig TE, Hayman SR, Dispenzieri A, Buadi F, Bergsagel PL, Gertz M, Dalton R, Mikhael J, Dingli D, Reeder CB, Lust JA, ... Russell S, et al. Survival in Patients with Newly Diagnosed Myeloma Undergoing Therapy with Lenalidomide and Dexamethasone: Impact of High-Risk Cytogenetic Risk Status on Outcome Blood. 112: 95-95. DOI: 10.1182/Blood.V112.11.95.95  0.1
2021 Budzik KM, Nace RA, Ikeda Y, Russell SJ. Oncolytic Foamy Virus - generation and properties of a nonpathogenic replicating retroviral vector system that targets chronically proliferating cancer cells. Journal of Virology. PMID 33692205 DOI: 10.1128/JVI.00015-21  0.1
2017 Tandon N, Sidana S, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Dingli D, Fonder AL, Hobbs MA, Hayman SR, Gonsalves WI, Hwa YL, Kapoor P, Kyle RA, Leung N, ... ... Russell SJ, et al. Treatment Patterns and Outcome Following Initial Relapse or Refractory Disease in Patients with Systemic Light Chain Amyloidosis. American Journal of Hematology. PMID 28314084 DOI: 10.1002/Ajh.24723  0.1
2013 Leung N, Glavey SV, Kumar S, Dispenzieri A, Buadi FK, Dingli D, Lacy MQ, Hayman SR, Lust JA, Russell SJ, Zeldenrust SR, Rajkumar SV, Gertz MA. A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision? Haematologica. 98: 988-92. PMID 23729727 DOI: 10.3324/Haematol.2012.079210  0.1
2014 Jing Y, Zaias J, Duncan R, Russell SJ, Merchan JR. In vivo safety, biodistribution and antitumor effects of uPAR retargeted oncolytic measles virus in syngeneic cancer models. Gene Therapy. 21: 289-97. PMID 24430235 DOI: 10.1038/gt.2013.84  0.1
2005 Piccini JP, Dalal D, Roguin A, Bomma C, Cheng A, Prakasa K, Dong J, Tichnell C, James C, Russell S, Crosson J, Berger RD, Marine JE, Tomaselli GF, Calkins H. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia Heart Rhythm. 2: 1188-1194. PMID 16253908 DOI: 10.1016/J.Hrthm.2005.08.022  0.099
2007 Iankov ID, Blechacz B, Liu C, Schmeckpeper JD, Tarara JE, Federspiel MJ, Caplice N, Russell SJ. Infected cell carriers: a new strategy for systemic delivery of oncolytic measles viruses in cancer virotherapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 114-22. PMID 17164782 DOI: 10.1038/sj.mt.6300020  0.099
2019 Liu M, Peng K, Federspiel M, Russell S, Brunton B, Zhou Y, Packiriswamy N, Hubbard J, Loprinzi C, Peethambaram P, Ruddy K, Allred J, Galanis E, Okuno S. Abstract P6-21-03: Phase I trial of intratumoral (IT) administration of a NIS-expressing derivative manufactured from a genetically engineered strain of measles virus (MV) Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P6-21-03  0.099
2020 Eckert EC, Nace RA, Tonne JM, Evgin L, Vile RG, Russell SJ. Generation of a Tumor-Specific Chemokine Gradient Using Oncolytic Vesicular Stomatitis Virus Encoding CXCL9. Molecular Therapy Oncolytics. 16: 63-74. PMID 31930167 DOI: 10.1016/J.Omto.2019.12.003  0.099
2021 Sakemura R, Bansal A, Siegler EL, Hefazi M, Yang N, Khadka RH, Newsom AN, Hansen MJ, Cox MJ, Manriquez Roman C, Schick KJ, Can I, Tapper EE, Nevala WK, Adada MM, ... ... Russell SJ, et al. Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-Cell Expansion, Trafficking, and Toxicity. Cancer Immunology Research. PMID 34244299 DOI: 10.1158/2326-6066.CIR-20-0901  0.099
2019 Tschautscher M, Jevremovic D, Buadi F, Lacy M, Gertz MA, Dispenzieri A, Kapoor P, Dingli D, Hayman SR, Lust JA, Russell SJ, Leung N, Go RS, Lin Y, Gonsalves WI, et al. Implications and outcomes of MRD-negative multiple myeloma patients with immunofixation positivity. Journal of Clinical Oncology. 37: 8034-8034. DOI: 10.1200/Jco.2019.37.15_Suppl.8034  0.099
2012 Lacy MQ, Kumar SK, LaPlant BR, Laumann K, Gertz MA, Hayman SR, Buadi FK, Dispenzieri A, Lust JA, Russell S, Dingli D, Zeldenrust SR, Fonseca R, Bergsagel P, Stewart K, et al. Pomalidomide Plus Low-Dose Dexamethasone (Pom/Dex) in Relapsed Myeloma: Long Term Follow up and Factors Predicing Outcome in 345 Patients Blood. 120: 201-201. DOI: 10.1182/Blood.V120.21.201.201  0.099
2018 Hwa YL, Gertz MA, Kumar SK, Lacy MQ, Buadi FK, Dingli D, Kapoor P, Zeldenrust S, Leung N, Hayman SR, Gonsalves WI, Kourelis T, Warsame R, Go RS, Muchtar E, ... ... Russell SJ, et al. Prognostic Restaging at the Time of 2nd-Line Therapy in Patients with AL Amyloidosis Blood. 132: 5594-5594. DOI: 10.1182/Blood-2018-99-113805  0.099
2020 Nandakumar B, Kapoor P, Binder M, Buadi FK, Lacy MQ, Gertz MA, Dispenzieri A, Dingli D, Hwa YL, Fonder A, Hobbs MA, Hayman SR, Lust JA, Russell SJ, Leung N, et al. Continued Improvement in Survival of Patients with Newly Diagnosed Multiple Myeloma (MM) Blood. 136: 30-31. DOI: 10.1182/blood-2020-140388  0.099
2012 Hutzen B, Pierson CR, Russell SJ, Galanis E, Raffel C, Studebaker AW. Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine. Bmc Cancer. 12: 508. PMID 23134812 DOI: 10.1186/1471-2407-12-508  0.098
2017 Tandon N, Sidana S, Rajkumar SV, Dispenzieri A, Gertz MA, Lacy MQ, Kyle RA, Buadi FK, Dingli D, Hayman SR, Fonder AL, Hobbs MA, Gonsalves WI, Kapoor P, Hwa YL, ... ... Russell SJ, et al. Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosis. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 1-6. PMID 28699793 DOI: 10.1080/13506129.2017.1351354  0.098
2016 Hwa YL, Kumar SK, Gertz MA, Lacy MQ, Buadi FK, Kourelis TV, Gonsalves WI, Rajkumar SV, Go RS, Leung N, Kapoor P, Dingli D, Kyle RA, Russell S, Lust JA, et al. Induction Therapy Pre-Autologous Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis: A Retrospective Evaluation. American Journal of Hematology. PMID 27341539 DOI: 10.1002/Ajh.24453  0.098
2018 Paquin AR, Kumar SK, Buadi FK, Gertz MA, Lacy MQ, Dispenzieri A, Dingli D, Hwa L, Fonder A, Hobbs M, Hayman SR, Zeldenrust SR, Lust JA, Russell SJ, Leung N, et al. Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome. Blood Cancer Journal. 8: 125. PMID 30538223 DOI: 10.1038/S41408-018-0163-7  0.098
2012 Reddi HV, Madde P, McDonough SJ, Trujillo MA, Morris JC, Myers RM, Peng KW, Russell SJ, McIver B, Eberhardt NL. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy. Cancer Gene Therapy. 19: 659-65. PMID 22790962 DOI: 10.1038/Cgt.2012.47  0.097
2010 Liu C, Russell SJ, Peng KW. Systemic therapy of disseminated myeloma in passively immunized mice using measles virus-infected cell carriers. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1155-64. PMID 20234340 DOI: 10.1038/mt.2010.43  0.097
2005 Myers R, Greiner S, Harvey M, Soeffker D, Frenzke M, Abraham K, Shaw A, Rozenblatt S, Federspiel MJ, Russell SJ, Peng KW. Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer. Cancer Gene Therapy. 12: 593-9. PMID 15746945 DOI: 10.1038/sj.cgt.7700823  0.097
2010 Studebaker AW, Kreofsky CR, Pierson CR, Russell SJ, Galanis E, Raffel C. Treatment of medulloblastoma with a modified measles virus. Neuro-Oncology. 12: 1034-42. PMID 20494960 DOI: 10.1093/neuonc/noq057  0.097
2007 Liu C, Sarkaria JN, Petell CA, Paraskevakou G, Zollman PJ, Schroeder M, Carlson B, Decker PA, Wu W, James CD, Russell SJ, Galanis E. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 7155-65. PMID 18056196 DOI: 10.1158/1078-0432.CCR-07-1306  0.097
2010 Li H, Peng KW, Dingli D, Kratzke RA, Russell SJ. Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy. Cancer Gene Therapy. 17: 550-8. PMID 20379224 DOI: 10.1038/cgt.2010.10  0.097
1995 Vile RG, Diaz RM, Miller N, Mitchell S, Tuszyanski A, Russell SJ. Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter. Virology. 214: 307-13. PMID 8525635 DOI: 10.1006/viro.1995.9923  0.097
2019 Muchtar E, Gertz MA, Kourelis TV, Sidana S, Go RS, Lacy MQ, Buadi FK, Dingli D, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Lisa Hwa Y, Gonsalves W, ... ... Russell S, et al. Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis. Leukemia. PMID 31758090 DOI: 10.1038/S41375-019-0655-X  0.097
2012 Penheiter AR, Russell SJ, Carlson SK. The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies. Current Gene Therapy. 12: 33-47. PMID 22263922 DOI: 10.2174/156652312799789235  0.097
2010 Ansell SM, Kyle RA, Reeder CB, Fonseca R, Mikhael JR, Morice WG, Bergsagel PL, Buadi FK, Colgan JP, Dingli D, Dispenzieri A, Greipp PR, Habermann TM, Hayman SR, Inwards DJ, ... ... Russell SJ, et al. Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines. Mayo Clinic Proceedings. 85: 824-33. PMID 20702770 DOI: 10.4065/Mcp.2010.0304  0.097
2018 Gonsalves WI, Buadi FK, Ailawadhi S, Bergsagel PL, Chanan Khan AA, Dingli D, Dispenzieri A, Fonseca R, Hayman SR, Kapoor P, Kourelis TV, Lacy MQ, Larsen JT, Muchtar E, Reeder CB, ... ... Russell SJ, et al. Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement. Bone Marrow Transplantation. PMID 29988062 DOI: 10.1038/S41409-018-0264-8  0.096
2017 Russell SJ, Peng KW. Oncolytic Virotherapy: A Contest between Apples and Oranges. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28392162 DOI: 10.1016/j.ymthe.2017.03.026  0.096
2001 Galanis E, Vile RG, Russell SJ. Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors Critical Reviews in Oncology Hematology. 38: 177-192. PMID 11369253 DOI: 10.1016/S1040-8428(01)00103-2  0.095
2004 Peng K, Timm MM, Dingli D, Dispenzieri A, Gertz M, Witzig TE, Greipp PR, Russell SJ. Oncolytic Measles Virus Selectively Targets CD46 Overexpression on Myeloma Cells. Blood. 104: 2392-2392. DOI: 10.1182/BLOOD.V104.11.2392.2392  0.095
2019 Muchtar E, Dispenzieri A, Jevremovic D, Dingli D, Buadi FK, Lacy MQ, Gonsalves W, Warsame R, Kourelis TV, Hayman SR, Kapoor P, Leung N, Russell S, Lust JA, Lin Y, et al. Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosis. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 1-4. PMID 31544536 DOI: 10.1080/13506129.2019.1666709  0.095
1995 Russell SJ. Replicating vectors for gene therapy of cancer: risks, limitations and prospects. European Journal of Cancer (Oxford, England : 1990). 1165-71. PMID 7654450 DOI: 10.1016/0959-8049(94)90477-4  0.095
2012 Russell SJ. Making high titer retroviral producer cells. Methods in Molecular Biology (Clifton, N.J.). 8: 29-44. PMID 21390698 DOI: 10.1385/0-89603-191-8:29  0.095
2017 Paludo J, Mikhael JR, LaPlant BR, Halvorson AE, Kumar S, Gertz MA, Hayman SR, Buadi FK, Dispenzieri A, Lust JA, Kapoor P, Leung N, Russell SJ, Dingli D, Go RS, et al. Pomalidomide, Bortezomib and Dexamethasone (PVD) for Patients with Relapsed, Lenalidomide Refractory Multiple Myeloma. Blood. PMID 28684537 DOI: 10.1182/Blood-2017-05-782961  0.094
2018 Packiriswamy N, Upreti D, Zhou Y, Dispenzieri A, Peng KW, Russell SJ. T cell responses to tumor associated antigens in multiple myeloma patients treated with MV-NIS, an oncolytic measles virus. Journal of Clinical Oncology. 36: 218-218. DOI: 10.1200/JCO.2018.36.5_SUPPL.218  0.094
2018 Packiriswamy N, Upreti D, Zhou Y, Dispenzieri A, Peng KW, Russell SJ. T cell responses to tumor associated antigens in multiple myeloma patients treated with MV-NIS, an oncolytic measles virus. Journal of Clinical Oncology. 36: 218-218. DOI: 10.1182/Blood.V130.Suppl_1.3793.3793  0.094
2005 Hummel H, Nakamura T, Kuntz G, Einsele H, Russell SJ, Topp MS. Fully Retargeted Oncolytic Measles Virus Specific for the WUE-Ag Results in Specific Lysis of Multiple Myeloma Cells. Blood. 106: 3053-3053. DOI: 10.1182/BLOOD.V106.11.3053.3053  0.094
2008 Bajzer Z, Carr T, Josić K, Russell SJ, Dingli D. Modeling of cancer virotherapy with recombinant measles viruses. Journal of Theoretical Biology. 252: 109-22. PMID 18316099 DOI: 10.1016/j.jtbi.2008.01.016  0.094
2016 Muchtar E, Dispenzieri A, Kumar SK, Buadi FK, Lacy MQ, Zeldenrust S, Hayman SR, Leung N, Kourelis TV, Gonsalves W, Chakraborty R, Russell S, Dingli D, Lust JA, Lin Y, et al. Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival. Leukemia. PMID 27211265 DOI: 10.1200/Jco.2016.34.15_Suppl.8016  0.094
2010 Gay F, Hayman SR, Lacy MQ, Buadi F, Gertz MA, Kumar S, Dispenzieri A, Mikhael JR, Bergsagel PL, Dingli D, Reeder CB, Lust JA, Russell SJ, Roy V, Zeldenrust SR, et al. Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients. Blood. 115: 1343-50. PMID 20008302 DOI: 10.1182/Blood-2009-08-239046  0.094
2019 Tandon N, Sidana S, Rajkumar SV, Gertz MA, Buadi FK, Lacy MQ, Kapoor P, Gonsalves WI, Dispenzieri A, Kourelis TV, Warsame R, Dingli D, Fonder AL, Hayman SR, Hobbs MA, ... ... Russell SJ, et al. Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma. Blood Advances. 3: 744-750. PMID 30824418 DOI: 10.1182/Bloodadvances.2018022806  0.094
2016 Muchtar E, Dispenzieri A, Kumar SK, Ketterling RP, Dingli D, Lacy MQ, Buadi FK, Hayman SR, Kapoor P, Leung N, Chakraborty R, Gonsalves W, Warsame R, Kourelis TV, Russell S, et al. Interphase fluorescence in-situ hybridization (iFISH) in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category. Leukemia. PMID 27904139 DOI: 10.1038/leu.2016.369  0.093
2017 Hwa YL, Warsame R, Gertz MA, Buadi FK, Lacy MQ, Kumar SK, Dingli D, Zeldenrust SR, Leung N, Hayman SR, Kapoor P, Gonsalves WI, Kourelis TV, Russell S, Go RS, et al. Delineation of the timing of second line therapy post- autologous stem cell transplant in patients with AL amyloidosis. Blood. PMID 28807981 DOI: 10.1182/Blood-2017-05-783415  0.093
2004 Blechacz B, Russell SJ. Parvovirus vectors: use and optimisation in cancer gene therapy. Expert Reviews in Molecular Medicine. 6: 1-24. PMID 15387896 DOI: 10.1017/S1462399404008026  0.093
2006 Hummel HD, Kuntz G, Nakamura T, Greiner A, Russell SJ, Einsele H, Topp MS. Fully Retargeted Oncolytic Measles Virus for Multiple Myeloma Therapy. Blood. 108: 5474-5474. DOI: 10.1182/blood.v108.11.5474.5474  0.093
2011 Gertz MA, Buadi FK, Hayman SR, Dingli D, Dispenzieri A, Greipp PR, Kumar S, Lacy MQ, Lust JA, Leung N, Rajkumar SV, Russell SJ, Zeldenrust SR, Mikhael JR, Roy V, et al. IgD Amyloidosis: An Unrecognized Entity Blood. 118: 5079-5079. DOI: 10.1182/Blood.V118.21.5079.5079  0.093
2017 Maroun J, Muñoz-Alía M, Ammayappan A, Schulze A, Peng KW, Russell S. Designing and building oncolytic viruses. Future Virology. 12: 193-213. PMID 29387140 DOI: 10.2217/fvl-2016-0129  0.093
2019 Sterner RM, Sakemura R, Yang N, Cox MJ, Khadka R, Forsman CL, Hansen MJ, Jin F, Ayasoufi K, Hefazi M, Welch BM, Schick KJ, Walters DK, Martinez G, Ahmed O, ... ... Russell SJ, et al. GM-CSF Blockade during Chimeric Antigen Receptor T-Cell (CART) Therapy Reduces Cytokine Release Syndrome and Neurotoxicity and May Enhance CART Effector Functions Biology of Blood and Marrow Transplantation. 25: S4. DOI: 10.1016/J.Bbmt.2018.12.686  0.093
2006 Galanis E, Hartmann LC, Cliby W, Zollman PJ, Peethambaram PP, Long HJ, Kaur JS, Sloan JA, Peng KW, Russell SJ. Phase I trial of intraperitoneal (IP) administration of a measles virus (MV) derivative expressing the human carcinoembryonic antigen (CEA) in ovarian cancer patients Journal of Clinical Oncology. 24: 5028-5028. DOI: 10.1200/JCO.2006.24.18_SUPPL.5028  0.093
2013 Touchefeu Y, Khan AA, Borst G, Zaidi SH, McLaughlin M, Roulstone V, Mansfield D, Kyula J, Pencavel T, Karapanagiotou EM, Clayton J, Federspiel MJ, Russell SJ, Garrett M, Collins I, et al. Optimising measles virus-guided radiovirotherapy with external beam radiotherapy and specific checkpoint kinase 1 inhibition. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 108: 24-31. PMID 23849174 DOI: 10.1016/J.Radonc.2013.05.036  0.092
2013 Elsedawy NB, Russell SJ. Oncolytic vaccines. Expert Review of Vaccines. 12: 1155-72. PMID 24124877 DOI: 10.1586/14760584.2013.836912  0.092
2015 Shen W, Patnaik MM, Ruiz A, Russell SJ, Peng KW. Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia. Blood. PMID 26712908 DOI: 10.1182/blood-2015-06-652503  0.092
2009 Jing Y, Tong C, Zhang J, Nakamura T, Iankov I, Russell SJ, Merchan JR. Tumor and vascular targeting of a novel oncolytic measles virus retargeted against the urokinase receptor. Cancer Research. 69: 1459-68. PMID 19208845 DOI: 10.1158/0008-5472.CAN-08-2628  0.092
2021 Muchtar E, Dispenzieri A, Gertz MA, Kumar SK, Buadi FK, Leung N, Lacy MQ, Dingli D, Ailawadhi S, Bergsagel PL, Fonseca R, Hayman SR, Kapoor P, Grogan M, Abou Ezzeddine OF, ... ... Russell SJ, et al. Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update. Mayo Clinic Proceedings. 96: 1546-1577. PMID 34088417 DOI: 10.1016/j.mayocp.2021.03.012  0.092
2020 Evans LA, Jevremovic D, Nandakumar B, Dispenzieri A, Buadi FK, Dingli D, Lacy MQ, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Muchtar E, Warsame R, ... ... Russell S, et al. Utilizing Multiparametric Flow Cytometry in the Diagnosis of Patients with Primary Plasma Cell Leukemia. American Journal of Hematology. PMID 32129510 DOI: 10.1002/Ajh.25773  0.091
2005 Allen C, McDonald C, Giannini C, Peng KW, Rosales G, Russell SJ, Galanis E. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas. The Journal of Gene Medicine. 6: 1216-27. PMID 15459967 DOI: 10.1002/jgm.616  0.091
2016 Muchtar E, Jevremovic D, Dispenzieri A, Dingli D, Buadi FK, Lacy MQ, Gonsalves W, Hayman SR, Kapoor P, Leung N, Russell S, Lust JA, Lin Y, Go RS, Chakraborty R, et al. The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first line treatment. Blood. PMID 27729322 DOI: 10.1182/Blood-2016-06-721878  0.091
2017 Kourelis T, Kapoor P, Dingli D, Stewart AK, Buadi F, Gertz MA, Lacy M, Kumar S, Gonsalves WI, Go RS, Lust JA, Hayman SR, Warsame RM, Rajkumar S, Zeldenrust SR, ... Russell SJ, et al. The use of proteasome inhibitors among patients with POEMS syndrome. Journal of Clinical Oncology. 35: e19530-e19530. DOI: 10.1200/Jco.2017.35.15_Suppl.E19530  0.091
2016 Binder M, Rajkumar SV, Ketterling RP, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Hayman SR, Hwa YL, Zeldenrust SR, Lust JA, Russell SJ, Leung N, Kapoor P, Go RS, et al. Prognostic Implications of Multiple Cytogenetic High-Risk Abnormalities in Patients with Newly Diagnosed Multiple Myeloma Blood. 128: 5615-5615. DOI: 10.1182/Blood.V128.22.5615.5615  0.091
2013 Ong HT, Federspiel MJ, Guo CM, Ooi LL, Russell SJ, Peng KW, Hui KM. Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth. Journal of Hepatology. 59: 999-1006. PMID 23867315 DOI: 10.1016/j.jhep.2013.07.010  0.091
2017 Msaouel P, Opyrchal M, Dispenzieri A, Peng KW, Federspiel MJ, Russell SJ, Galanis E. Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects. Current Cancer Drug Targets. PMID 28228086 DOI: 10.2174/1568009617666170222125035  0.091
2019 Nandakumar B, Kumar SK, Dispenzieri A, Buadi FK, Dingli D, Lacy MQ, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Muchtar E, Warsame R, Kourelis TV, ... Russell S, et al. Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy. Clinical Lymphoma, Myeloma & Leukemia. PMID 31685378 DOI: 10.1016/J.Clml.2019.09.624  0.09
2006 Goel A, Dispenzieri A, Geyer SM, Greiner S, Peng KW, Russell SJ. Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP skeletally targeted radiotherapy in an orthotopic model of multiple myeloma Blood. 107: 4063-4070. PMID 16424391 DOI: 10.1182/Blood-2005-09-3870  0.09
2017 Tandon N, Sidana S, Dispenzieri A, Gertz MA, Lacy MQ, Dingli D, Buadi FK, Fonder AL, Hayman SR, Hwa YL, Hobbs MA, Kapoor P, Gonsalves WI, Leung N, Go RS, ... ... Russell SJ, et al. Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL). American Journal of Hematology. PMID 28960427 DOI: 10.1002/Ajh.24919  0.09
2011 Kumar SK, Gertz MA, Lacy MQ, Dingli D, Hayman SR, Buadi FK, Short-Detweiler K, Zeldenrust SR, Leung N, Greipp PR, Lust JA, Russell SJ, Kyle RA, Rajkumar SV, Dispenzieri A. Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score. Mayo Clinic Proceedings. 86: 12-8. PMID 21193650 DOI: 10.4065/Mcp.2010.0480  0.09
2005 Rajkumar SV, Hayman SR, Lacy MQ, Dispenzieri A, Geyer SM, Kabat B, Zeldenrust SR, Kumar S, Greipp PR, Fonseca R, Lust JA, Russell SJ, Kyle RA, Witzig TE, Gertz MA. Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma. Blood. 106: 4050-3. PMID 16118317 DOI: 10.1182/Blood-2005-07-2817  0.09
2017 Naik S, Galyon GD, Jenks NJ, Steele MB, Miller AC, Allstadt SD, Suksanpaisan L, Peng KW, Federspiel MJ, Russell SJ, LeBlanc AK. Comparative oncology evaluation of intravenous recombinant oncolytic Vesicular Stomatitis Virus therapy in spontaneous canine cancer. Molecular Cancer Therapeutics. PMID 29158470 DOI: 10.1158/1535-7163.MCT-17-0432  0.09
2004 Zhang J, Frolov I, Russell SJ. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein. The Journal of Gene Medicine. 6: 1082-91. PMID 15368589 DOI: 10.1002/Jgm.605  0.09
2013 Humeniuk MS, Gertz MA, Lacy MQ, Kyle RA, Witzig TE, Kumar SK, Kapoor P, Lust JA, Hayman SR, Buadi FK, Rajkumar SV, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, et al. Outcomes of patients with POEMS syndrome treated initially with radiation. Blood. 122: 68-73. PMID 23699599 DOI: 10.1182/Blood-2013-03-487025  0.09
2004 Pham LD, Greiner S, Nakamura T, Peng K, Rosales GA, Bailey KR, Kao PC, Russell SJ. 306. Noninvasive Monitoring of Transgene Expression Using Surrogate Marker Peptides Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.248  0.09
2017 Lakshman A, Abeykoon JP, Kumar S, Rajkumar S, Kourelis T, Buadi F, Dingli D, Lacy M, Gonsalves WI, Dispenzieri A, Kyle RA, Lin Y, Go RS, Warsame RM, Hayman SR, ... Russell S, et al. Daratumumab-based combination therapies (DCT) in heavily-pretreated patients (pts) with relapsed and/or refractory multiple myeloma (RRMM). Journal of Clinical Oncology. 35: 8038-8038. DOI: 10.1200/Jco.2017.35.15_Suppl.8038  0.089
2018 Ravi P, Kumar SK, Roeker L, Gonsalves W, Buadi F, Lacy MQ, Go RS, Dispenzieri A, Kapoor P, Lust JA, Dingli D, Lin Y, Russell SJ, Leung N, Gertz MA, et al. Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma. Blood Cancer Journal. 8: 116. PMID 30442928 DOI: 10.1038/S41408-018-0140-1  0.089
2004 Nakamura T, Peng K, Vongpunsawad S, Harvey M, Mizuguchi H, Hayakawa T, Cattaneo R, Russell SJ. 24. Antibody-Targeted Fusion Provides a Versatile Platform for Novel Targeted Therapies Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.05.047  0.089
2002 Maurice M, Verhoeyen E, Salmon P, Trono D, Russell SJ, Cosset FL. Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide Blood. 99: 2342-2350. PMID 11895766 DOI: 10.1182/Blood.V99.7.2342  0.089
2005 Goel A, Dispenzieri A, Greipp PR, Witzig TE, Mesa RA, Russell SJ. PS-341-mediated selective targeting of multiple myeloma cells by synergistic increase in ionizing radiation-induced apoptosis. Experimental Hematology. 33: 784-95. PMID 15963854 DOI: 10.1016/J.Exphem.2005.04.005  0.089
2012 Penheiter AR, Dingli D, Bender CE, Russell SJ, Carlson SK. Monitoring the initial delivery of an oncolytic measles virus encoding the human sodium iodide symporter to solid tumors using contrast-enhanced computed tomography. The Journal of Gene Medicine. 14: 590-7. PMID 23015290 DOI: 10.1002/jgm.2670  0.089
2005 Mehra MR, Benza R, Deng MC, Russell S, Webber S. Surrogate markers for late cardiac allograft survival. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 4: 1184-91. PMID 15196080 DOI: 10.1111/j.1600-6143.2004.00485.x  0.089
2010 Dispenzieri A, Dingli D, Kumar SK, Rajkumar SV, Lacy MQ, Hayman S, Buadi F, Zeldenrust S, Leung N, Detweiler-Short K, Lust JA, Russell SJ, Kyle RA, Gertz MA. Discordance between serum cardiac biomarker and immunoglobulin-free light-chain response in patients with immunoglobulin light-chain amyloidosis treated with immune modulatory drugs. American Journal of Hematology. 85: 757-9. PMID 20872958 DOI: 10.1002/Ajh.21822  0.089
2012 Raval GG, Gertz MA, Lacy MQ, Hayman SR, Kumar SK, Buadi FK, Lust JA, Zeldenrust S, Dingli D, Hall RL, Hwa L, Lin Y, Kapoor P, Witzig TE, Kyle RA, ... Russell S, et al. Survival After Second, Third, and Fourth Line Therapy Better Than Expected in Patients with Previously Treated AL Amyloidosis Who Were Not Transplant Candidates At Diagnosis. Blood. 120: 946-946. DOI: 10.1182/Blood.V120.21.946.946  0.089
2017 Muchtar E, Gertz MA, Kyle RA, Lacy MQ, Dingli D, Leung N, Buadi FK, Hayman SR, Kapoor P, Hwa YL, Fonder A, Hobbs M, Gonsalves WI, Kourelis T, Warsame R, ... Russell SJ, et al. What Does AL Amyloidosis Look like in the Era of Mass Spectrometry Typing Blood. 130: 4353-4353. DOI: 10.1182/Blood.V130.Suppl_1.4353.4353  0.089
2007 Haralambieva I, Iankov I, Hasegawa K, Harvey M, Russell SJ, Peng KW. Engineering oncolytic measles virus to circumvent the intracellular innate immune response. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 588-97. PMID 17245355 DOI: 10.1038/sj.mt.6300076  0.089
2006 Greipp PT, Collins DA, Russell SJ, Harvey ME, Goel A, Greipp PR. In-111DAC Is a Novel Technique To Image Multiple Myeloma. Blood. 108: 3488-3488. DOI: 10.1182/Blood.V108.11.3488.3488  0.088
2001 Russell SJ, Dunbar CE. Gene therapy approaches for multiple myeloma. Seminars in Hematology. 38: 268-75. PMID 11486315 DOI: 10.1016/S0037-1963(01)90019-8  0.088
2016 Zhang L, Steele MB, Jenks N, Grell J, Suksanpaisan L, Naik S, Federspiel MJ, Lacy MQ, Russell SJ, Peng KW. Safety studies in tumor and non-tumor bearing mice in support of clinical trials using oncolytic VSV-IFNβ-NIS. Human Gene Therapy. Clinical Development. PMID 27532609 DOI: 10.1089/humc.2016.061  0.088
2017 Jacobson BA, Sadiq AA, Tang S, Jay-Dixon J, Patel MR, Drees J, Sorenson BS, Russell SJ, Kratzke RA. Cap-dependent translational control of oncolytic measles virus infection in malignant mesothelioma. Oncotarget. PMID 28666265 DOI: 10.18632/oncotarget.18656  0.088
2011 Buadi F, Lacy M, Dispenzieri A, LaPlant B, Laumann KM, Nowakowski GS, Hayman SR, Detweiler Short K, Dingli D, Gertz MA, Greipp PR, Lust JA, Witzig TE, Zeldenrust SR, Russell SJ, et al. Single-agent lenalidomide for newly diagnosed myeloma with on-demand dexamethasone: A phase II trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 8080. PMID 28023470 DOI: 10.1200/jco.2011.29.15_suppl.8080  0.088
2021 Muñoz-Alía MÁ, Nace RA, Tischer A, Zhang L, Bah ES, Auton M, Russell SJ. Mev-stealth: A cd46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum. Plos Pathogens. 17: e1009283. PMID 33534834 DOI: 10.1371/journal.ppat.1009283  0.088
2019 Goyal G, Rajkumar SV, Lacy MQ, Gertz MA, Buadi FK, Dispenzieri A, Hwa YL, Fonder AL, Hobbs MA, Hayman SR, Zeldenrust SR, Lust JA, Russell SJ, Leung N, Kapoor P, et al. Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma. Leukemia. PMID 30787429 DOI: 10.1038/S41375-019-0419-7  0.087
2010 Iankov ID, Msaouel P, Allen C, Federspiel MJ, Bulur PA, Dietz AB, Gastineau D, Ikeda Y, Ingle JN, Russell SJ, Galanis E. Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model. Breast Cancer Research and Treatment. 122: 745-54. PMID 19894113 DOI: 10.1007/S10549-009-0602-Z  0.087
2020 Cochrane AB, Lyster H, Lindenfeld J, Doligalski C, Baran D, Yost C, Shullo M, Schweiger M, Weill D, Stuckey L, Ivulich S, Scheel J, Peters L, Colvin M, Dawson K, ... ... Russell S, et al. Report from the 2018 consensus conference on immunomodulating agents in thoracic transplantation: Access, formulations, generics, therapeutic drug monitoring, and special populations. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. PMID 32883559 DOI: 10.1016/j.healun.2020.06.024  0.087
2016 Mullikin TC, Rajkumar SV, Dispenzieri A, Buadi FK, Lacy MQ, Lin Y, Dingli D, Go RS, Hayman SR, Zeldenrust SR, Russell SJ, Lust JA, Leung N, Kapoor P, Kyle RA, et al. Clinical characteristics and outcomes in biclonal gammopathies. American Journal of Hematology. PMID 26840395 DOI: 10.1002/Ajh.24319  0.087
2005 Hallak LK, Merchan JR, Storgard CM, Loftus JC, Russell SJ. Targeted measles virus vector displaying echistatin infects endothelial cells via alpha(v)beta3 and leads to tumor regression. Cancer Research. 65: 5292-300. PMID 15958576 DOI: 10.1158/0008-5472.CAN-04-2879  0.087
2009 Msaouel P, Iankov ID, Allen C, Aderca I, Federspiel MJ, Tindall DJ, Morris JC, Koutsilieris M, Russell SJ, Galanis E. Noninvasive imaging and radiovirotherapy of prostate cancer using an oncolytic measles virus expressing the sodium iodide symporter. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 2041-8. PMID 19773744 DOI: 10.1038/Mt.2009.218  0.087
2012 Iankov ID, Allen C, Federspiel MJ, Myers RM, Peng KW, Ingle JN, Russell SJ, Galanis E. Expression of immunomodulatory neutrophil-activating protein of Helicobacter pylori enhances the antitumor activity of oncolytic measles virus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 1139-47. PMID 22334023 DOI: 10.1038/mt.2012.4  0.087
2010 Jenks N, Myers R, Greiner SM, Thompson J, Mader EK, Greenslade A, Griesmann GE, Federspiel MJ, Rakela J, Borad MJ, Vile RG, Barber GN, Meier TR, Blanco MC, Carlson SK, ... Russell SJ, et al. Safety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primates. Human Gene Therapy. 21: 451-62. PMID 19911974 DOI: 10.1089/Hum.2009.111  0.087
2016 Muchtar E, Dean D, Dispenzieri A, Dingli D, Buadi FK, Lacy MQ, Gonsalves WI, Hayman SR, Kapoor P, Leung N, Russell SJ, Lust JA, Go RS, Lin Y, Chakraborty R, et al. Thyroid Functional Abnormalities in Newly Diagnosed AL Amyloidosis: Frequency and Influence By Type of Organ Involvement and Disease Burden Blood. 128: 3273-3273. DOI: 10.1182/Blood.V128.22.3273.3273  0.087
2012 Khan ML, Reeder CB, Kumar SK, Lacy MQ, Reece DE, Dispenzieri A, Gertz MA, Greipp P, Hayman S, Zeldenhurst S, Dingli D, Lust J, Russell S, Laumann KM, Mikhael JR, et al. A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma. British Journal of Haematology. 156: 326-33. PMID 22107129 DOI: 10.1111/J.1365-2141.2011.08949.X  0.086
2003 Caplice NM, Bunch TJ, Stalboerger PG, Wang S, Simper D, Miller DV, Russell SJ, Litzow MR, Edwards WD. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proceedings of the National Academy of Sciences of the United States of America. 100: 4754-9. PMID 12665618 DOI: 10.1073/pnas.0730743100  0.086
2011 Dispenzieri A, Gertz MA, Saenger AK, Grogan M, Kumar S, Lacy MQ, Kyle RA, Leung N, Zeldenrust S, Hayman SR, Buadi FK, Greipp PR, Rajkumar SV, Russell S, Dingli D, et al. The Utility of High Sensitivity Cardiac Troponin Among Patients with Immunoglobulin Light Chain Amyloidosis Blood. 118: 2887-2887. DOI: 10.1182/Blood.V118.21.2887.2887  0.086
2006 McDonald CJ, Erlichman C, Ingle JN, Rosales GA, Allen C, Greiner SM, Harvey ME, Zollman PJ, Russell SJ, Galanis E. A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer. Breast Cancer Research and Treatment. 99: 177-84. PMID 16642271 DOI: 10.1007/s10549-006-9200-5  0.086
2013 Ammayappan A, Peng KW, Russell SJ. Characteristics of oncolytic vesicular stomatitis virus displaying tumor-targeting ligands. Journal of Virology. 87: 13543-55. PMID 24089573 DOI: 10.1128/JVI.02240-13  0.086
2009 Madan S, Dispenzieri A, Lacy MQ, Buadi F, Hayman SR, Detweiler K, Zeldenrust SR, Dingli D, Greipp PR, Russell SJ, Lust JA, Kyle RA, Rajkumar SV, Gertz MA, Kumar SK. Clinical Features and Treatment Response of Light Chain (AL) Amyloidosis Diagnosed in Patients with Previous Diagnosis of Multiple Myeloma (MM). Blood. 114: 4867-4867. DOI: 10.1182/blood.V114.22.4867.4867  0.086
2015 Ruiz AJ, Russell SJ. MicroRNAs and oncolytic viruses. Current Opinion in Virology. 13: 40-48. PMID 25863717 DOI: 10.1016/j.coviro.2015.03.007  0.086
2013 Ammayappan A, Nace R, Peng KW, Russell SJ. Neuroattenuation of vesicular stomatitis virus through picornaviral internal ribosome entry sites. Journal of Virology. 87: 3217-28. PMID 23283963 DOI: 10.1128/JVI.02984-12  0.086
2012 Gertz MA, Buadi FK, Hayman SR, Dingli D, Dispenzieri A, Greipp PR, Kumar SK, Lacy MQ, Lust JA, Leung N, Rajkumar SV, Russell SJ, Zeldenrust SR, Mikhael JR, Roy V, et al. Immunoglobulin D amyloidosis: a distinct entity. Blood. 119: 44-8. PMID 22065594 DOI: 10.1182/Blood-2011-06-358895  0.086
2014 Warsame R, Bang SM, Kumar SK, Gertz MA, Lacy MQ, Buadi F, Dingli D, Hayman SR, Kapoor P, Kyle RA, Leung N, Lust JA, Russell SJ, Witzig TE, Zeldenrust SR, et al. Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant. European Journal of Haematology. 92: 485-90. PMID 24502602 DOI: 10.1111/Ejh.12282  0.086
2014 Konold C, Higgins T, Russell SJ, Khalil K. Data seen through different lenses Educational Studies in Mathematics. 1-21. DOI: 10.1007/s10649-013-9529-8  0.086
2020 Rashidinejad P, Hu X, Russell S. Patient-adaptable intracranial pressure morphology analysis using a probabilistic model-based approach. Physiological Measurement. PMID 32992304 DOI: 10.1088/1361-6579/abbcbb  0.086
2017 Gonsalves WI, Rajkumar SV, Dispenzieri A, Lacy M, Buadi F, Dingli D, Go RS, Kapoor P, Hayman SR, Lust JA, Leung N, Russell SJ, Zeldenrust SR, Lin Y, Hwa YL, et al. The impact of body mass index on the risk of early progression of smoldering multiple myeloma to symptomatic myeloma. Journal of Clinical Oncology. 35: 8032-8032. DOI: 10.1200/Jco.2017.35.15_Suppl.8032  0.085
2009 Kapoor P, Kumar S, Fonseca R, Lacy MQ, Witzig TE, Hayman SR, Dispenzieri A, Buadi F, Bergsagel PL, Gertz MA, Dalton RJ, Mikhael JR, Dingli D, Reeder CB, Lust JA, ... Russell SJ, et al. Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone. Blood. 114: 518-21. PMID 19324902 DOI: 10.1182/Blood-2009-01-202010  0.085
1997 Brissinck J, Russell SJ. Vaccine strategies in non-Hodgkin's lymphomas. Bailliere's Clinical Haematology. 9: 799-817. PMID 9138618 DOI: 10.1016/S0950-3536(96)80054-0  0.085
2016 Kourelis TV, Nasr SH, Dispenzieri A, Kumar SK, Gertz MA, Fervenza FC, Buadi FK, Lacy MQ, Erickson SB, Cosio FG, Kapoor P, Lust JA, Hayman SR, Rajkumar V, Zeldenrust SR, ... Russell SJ, et al. Outcomes of patients with renal monoclonal immunoglobulin deposition disease. American Journal of Hematology. PMID 27501122 DOI: 10.1002/Ajh.24528  0.085
2015 Patel MR, Jacobson BA, Ji Y, Drees J, Tang S, Xiong K, Wang H, Prigge JE, Dash AS, Kratzke AK, Mesev E, Etchison R, Federspiel MJ, Russell SJ, Kratzke RA. Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer. Oncotarget. PMID 26431376 DOI: 10.18632/oncotarget.5320  0.085
2017 Cattaneo R, Russell SJ. How to develop viruses into anticancer weapons. Plos Pathogens. 13: e1006190. PMID 28301602 DOI: 10.1371/Journal.Ppat.1006190  0.085
2004 Goel A, Dispenzieri A, Greipp PR, Witzig TE, Mesa RA, Russell SJ. PS-341 Induces Selective Radiosensitization of Multiple Myeloma Cells. Blood. 104: 2478-2478. DOI: 10.1182/Blood.V104.11.2478.2478  0.085
2017 Ruiz AJ, Russell SJ. MicroRNA-based Regulation of Picornavirus Tropism. Journal of Visualized Experiments : Jove. PMID 28287517 DOI: 10.3791/55033  0.085
2021 Agbor-Enoh S, Shah P, Tunc I, Hsu S, Russell S, Feller E, Shah K, Rodrigo ME, Najjar SS, Kong H, Pirooznia M, Fideli U, Bikineyeva A, Marishta A, Bhatti K, et al. Cell-Free DNA to Detect Heart Allograft Acute Rejection. Circulation. PMID 33435695 DOI: 10.1161/CIRCULATIONAHA.120.049098  0.084
2019 Zhang L, Suksanpaisan L, Jiang H, DeGrado TR, Russell SJ, Zhao M, Peng KW. Dual-Isotope SPECT Imaging with NIS Reporter Gene and Duramycin to Visualize Tumor Susceptibility to Oncolytic Virus Infection. Molecular Therapy Oncolytics. 15: 178-185. PMID 31890867 DOI: 10.1016/J.Omto.2019.10.002  0.084
2009 Liu C, Hasegawa K, Russell SJ, Sadelain M, Peng KW. Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer. The Prostate. 69: 1128-41. PMID 19367568 DOI: 10.1002/Pros.20962  0.084
2009 Msaouel P, Iankov ID, Allen C, Morris JC, von Messling V, Cattaneo R, Koutsilieris M, Russell SJ, Galanis E. Engineered measles virus as a novel oncolytic therapy against prostate cancer. The Prostate. 69: 82-91. PMID 18973133 DOI: 10.1002/Pros.20857  0.084
2019 Hwa YL, Gertz MA, Kumar SK, Lacy MQ, Buadi FK, Dingli D, Kapoor P, Zeldenrust SR, Leung N, Hayman SR, Gonsalves WI, Kourelis TV, Warsame R, Go RS, Muchtar E, ... ... Russell S, et al. Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis. Leukemia. PMID 30737485 DOI: 10.1038/S41375-019-0400-5  0.084
1997 Zhang J, Russell SJ. Vectors for cancer gene therapy. Cancer Metastasis Reviews. 15: 385-401. PMID 9034598 DOI: 10.1007/BF00046349  0.084
2021 Concilio SC, Russell SJ, Peng KW. A brief review of reporter gene imaging in oncolytic virotherapy and gene therapy. Molecular Therapy Oncolytics. 21: 98-109. PMID 33981826 DOI: 10.1016/j.omto.2021.03.006  0.084
2008 Liu C, Erlichman C, McDonald CJ, Ingle JN, Zollman P, Iankov I, Russell SJ, Galanis E. Heat shock protein inhibitors increase the efficacy of measles virotherapy. Gene Therapy. 15: 1024-34. PMID 18356818 DOI: 10.1038/gt.2008.30  0.084
2002 Sanz L, Kristensen P, Russell SJ, Ramirez García JR, Alvarez-Vallina L. Generation and characterization of recombinant human antibodies specific for native laminin epitopes: potential application in cancer therapy. Cancer Immunology, Immunotherapy : Cii. 50: 557-65. PMID 11776378 DOI: 10.1007/s00262-001-0235-5  0.084
2007 Waehler R, Russell SJ, Curiel DT. Engineering targeted viral vectors for gene therapy Nature Reviews Genetics. 8: 573-587. PMID 17607305 DOI: 10.1038/Nrg2141  0.084
2021 Evans L, Kumar S, Dingli D, Dispenzieri A, Lacy M, Go RS, Buadi F, Leung N, Lin Y, Hayman SR, Russell SJ, Muchtar E, Kapoor P, Siddiqui MA, Warsame RM, et al. Impact of stratifying levels of serum lactate dehydrogenase (LDH) at diagnosis on the overall survival (OS) in newly diagnosed multiple myeloma (NDMM). Journal of Clinical Oncology. 39: e20016-e20016. DOI: 10.1200/JCO.2021.39.15_SUPPL.E20016  0.083
2012 Warsame R, Gertz MA, Lacy MQ, Kyle RA, Buadi F, Dingli D, Greipp PR, Hayman SR, Kumar SK, Lust JA, Russell SJ, Witzig TE, Mikhael J, Leung N, Zeldenrust SR, et al. Trends and outcomes of modern staging of solitary plasmacytoma of bone. American Journal of Hematology. 87: 647-51. PMID 22549792 DOI: 10.1002/Ajh.23201  0.083
2017 Sidana S, Rajkumar SV, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Hayman SR, Dingli D, Kapoor P, Gonsalves WI, Go RS, Hwa YL, Leung N, Fonder AL, Hobbs MA, ... ... Russell SJ, et al. Clinical Presentation and Outcomes of Patients with Type 1 Monoclonal Cryoglobulinemia. American Journal of Hematology. PMID 28370486 DOI: 10.1002/Ajh.24745  0.083
2017 Lakshman A, Moustafa MA, Rajkumar SV, Dispenzieri A, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Hwa YL, Kapoor P, Leung N, ... ... Russell SJ, et al. Natural history of t(11;14) multiple myeloma. Leukemia. PMID 28655925 DOI: 10.1038/leu.2017.204  0.083
2018 Lakshman A, Rajkumar SV, Buadi FK, Binder M, Gertz MA, Lacy MQ, Dispenzieri A, Dingli D, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Hwa YL, Kapoor P, Leung N, ... ... Russell SJ, et al. Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria. Blood Cancer Journal. 8: 59. PMID 29895887 DOI: 10.1038/S41408-018-0077-4  0.083
2017 Warsame R, Kumar SK, Gertz MA, Lacy MQ, Buadi FK, Hayman SR, Leung N, Dingli D, Lust JA, Lin Y, Russell S, Kapoor P, Go RS, Kourelis T, Gonsalves W, et al. Hematology Patient Reported Symptom Screen to Assess Quality of Life for AL Amyloidosis. American Journal of Hematology. PMID 28181278 DOI: 10.1002/Ajh.24676  0.083
2015 Tesfay MZ, Ammayappan A, Federspiel MJ, Barber GN, Stojdl D, Peng KW, Russell SJ. Correction to Vesiculovirus neutralization by natural IgM and complement [Journal of Virology, 88, 11 (2014), 6148-6157] Journal of Virology. 89: 1945-1946. DOI: 10.1128/Jvi.03326-14  0.083
2017 Lakshman A, Alhaj Moustafa M, Rajkumar S, Dispenzieri A, Gertz MA, Buadi F, Lacy M, Dingli D, Hayman SR, Gonsalves WI, Kapoor P, Leung N, Lin Y, Go RS, Kourelis T, ... ... Russell S, et al. Natural history of t(11;14) multiple myeloma (MM). Journal of Clinical Oncology. 35: 8014-8014. DOI: 10.1200/Jco.2017.35.15_Suppl.8014  0.083
2013 Kourelis TV, Gertz M, Zent C, Lacy M, Kyle R, Kapoor P, Zeldenrust S, Buadi F, Witzig T, Hayman S, Lust J, Russell S, Lin Y, Rajkumar VS, Kumar S, et al. Systemic amyloidosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma. American Journal of Hematology. 88: 375-8. PMID 23508840 DOI: 10.1002/ajh.23413  0.083
2012 Kumar S, Fonseca R, Ketterling RP, Dispenzieri A, Lacy MQ, Gertz MA, Hayman SR, Buadi FK, Dingli D, Knudson RA, Greenberg A, Russell SJ, Zeldenrust SR, Lust JA, Kyle RA, et al. Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics. Blood. 119: 2100-5. PMID 22234687 DOI: 10.1182/Blood-2011-11-390658  0.082
2018 Brunton B, Suksanpaisan L, Li H, Liu Q, Yu Y, Vrieze A, Zhang L, Jenks N, Jiang H, DeGrado TR, Zhao C, Russell SJ, Peng KW. New transgenic NIS reporter rats for longitudinal tracking of fibrogenesis by high-resolution imaging. Scientific Reports. 8: 14209. PMID 30242176 DOI: 10.1038/S41598-018-32442-X  0.082
2017 Sidana S, Tandon N, Dispenzieri A, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Hwa YL, Kapoor P, Kyle RA, Leung N, ... ... Russell SJ, et al. Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains. Leukemia. PMID 28919633 DOI: 10.1038/leu.2017.286  0.082
2016 Kourelis TV, Buadi FK, Kumar SK, Gertz MA, Lacy MQ, Dingli D, Go RS, Kapoor P, Lust JA, Hayman SR, Hwa Y, Rajkumar SV, Zeldenrust SR, Russell SJ, Lin Y, et al. Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience. American Journal of Hematology. PMID 26972803 DOI: 10.1002/Ajh.24356  0.082
2003 Russell SJ. RNA viruses as virotherapy agents. Cancer Gene Therapy. 9: 961-6. PMID 12522435 DOI: 10.1038/sj.cgt.7700535  0.082
2006 Allen C, Vongpunsawad S, Nakamura T, James CD, Schroeder M, Cattaneo R, Giannini C, Krempski J, Peng KW, Goble JM, Uhm JH, Russell SJ, Galanis E. Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity. Cancer Research. 66: 11840-50. PMID 17178881 DOI: 10.1158/0008-5472.Can-06-1200  0.082
2010 Lech PJ, Russell SJ. Use of attenuated paramyxoviruses for cancer therapy. Expert Review of Vaccines. 9: 1275-302. PMID 21087107 DOI: 10.1586/erv.10.124  0.082
2020 Nagalo BM, Breton CA, Zhou Y, Arora M, Bogenberger JM, Barro O, Steele MB, Jenks NJ, Baker AT, Duda DG, Roberts LR, Russell SJ, Peng KW, Borad MJ. Oncolytic Virus With Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers. Molecular Therapy Oncolytics. PMID 32839735 DOI: 10.1016/j.omto.2020.08.007  0.081
2017 Kapoor P, Ansell SM, Fonseca R, Chanan-Khan A, Kyle RA, Kumar SK, Mikhael JR, Witzig TE, Mauermann M, Dispenzieri A, Ailawadhi S, Stewart AK, Lacy MQ, Thompson CA, Buadi FK, ... ... Russell SJ, et al. Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016. Jama Oncology. PMID 28056114 DOI: 10.1001/Jamaoncol.2016.5763  0.081
2015 Tesfay MZ, Ammayappan A, Federspiel MJ, Barber GN, Peng K, Russell SJ. 428. VSV Produced in CD55 Expressing Cells Has Better Resistance To Neutralization With Non-Immune Human Serum Molecular Therapy. 23: S169. DOI: 10.1016/S1525-0016(16)34037-0  0.081
2016 Tandon N, Rajkumar S, Lacy M, Dispenzieri A, Buadi F, Gertz MA, Hayman SR, Leung N, Go RS, Dingli D, Kapoor P, Lin Y, Hwa YL, Fonder A, Hobbs M, ... ... Russell S, et al. Clinical utility of the revised international staging system (RISS) in newly diagnosed multiple myeloma. Journal of Clinical Oncology. 34: 8017-8017. DOI: 10.1200/Jco.2016.34.15_Suppl.8017  0.081
2007 Blechacz B, Splinter PL, Greiner S, Myers R, Peng KW, Federspiel MJ, Russell SJ, LaRusso NF. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma. Hepatology (Baltimore, Md.). 44: 1465-77. PMID 17133484 DOI: 10.1002/hep.21437  0.081
1996 Valsesia-Wittmann S, Morling FJ, Nilson BH, Takeuchi Y, Russell SJ, Cosset FL. Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU. Journal of Virology. 70: 2059-64. PMID 8627737 DOI: 10.1128/jvi.70.3.2059-2064.1996  0.081
2020 Muchtar E, Gertz MA, Kourelis TV, Sidana S, Go RS, Lacy MQ, Buadi FK, Dingli D, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Gonsalves W, ... ... Russell S, et al. Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis. Leukemia. PMID 32728185 DOI: 10.1038/S41375-020-0993-8  0.081
2013 Peng KW, Myers R, Greenslade A, Mader E, Greiner S, Federspiel MJ, Dispenzieri A, Russell SJ. Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses. Gene Therapy. 20: 255-61. PMID 22476202 DOI: 10.1038/gt.2012.31  0.081
2009 Aravamudan B, Tong C, Lacy MQ, Hayman S, Buadi F, Gertz MA, Kumar S, Russell SJ, Dispenzieri A. Analysis of the Immunoglobulin Heavy and Light Chain Gene Expression and Mutations in POEMS Patients. Blood. 114: 4986-4986. DOI: 10.1182/Blood.V114.22.4986.4986  0.08
2000 Fielding AK, Chapel-Fernandes S, Chadwick MP, Bullough FJ, Cosset FL, Russell SJ. A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display. Human Gene Therapy. 11: 817-26. PMID 10779159 DOI: 10.1089/10430340050015437  0.08
2007 Lacy MQ, Gertz MA, Dispenzieri A, Hayman SR, Geyer S, Kabat B, Zeldenrust SR, Kumar S, Greipp PR, Fonseca R, Lust JA, Russell SJ, Kyle RA, Witzig TE, Bergsagel PL, et al. Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma. Mayo Clinic Proceedings. 82: 1179-84. PMID 17908524 DOI: 10.4065/82.10.1179  0.08
2015 Moulay G, Ohtani T, Ogut O, Guenzel A, Behfar A, Zakeri R, Haines P, Storlie J, Bowen L, Pham L, Kaye D, Sandhu G, O'Connor M, Russell S, Redfield M. Cardiac AAV9 Gene Delivery Strategies in Adult Canines: Assessment by Long-term Serial SPECT Imaging of Sodium Iodide Symporter Expression. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 1211-21. PMID 25915925 DOI: 10.1038/Mt.2015.78  0.08
2012 Msaouel P, Iankov ID, Allen C, Russell SJ, Galanis E. Oncolytic measles virus retargeting by ligand display. Methods in Molecular Biology (Clifton, N.J.). 797: 141-62. PMID 21948475 DOI: 10.1007/978-1-61779-340-0_11  0.08
2017 Orme J, Go RS, Kumar SK, Dispenzieri A, Gertz MA, Buadi FK, Dingli D, Leung N, Lacy MQ, Kapoor P, Lust JA, Lin Y, Russell SJ, Hayman SR, Zeldenrust S, et al. Disparities in Outcomes of Patients with Multiple Myeloma Based on Geographic Distance from NCI-Designated Cancer Centers: A SEER Based Analysis Blood. 130: 4689-4689. DOI: 10.1182/Blood.V130.Suppl_1.4689.4689  0.08
2020 Vandergaast R, Carey T, Reiter S, Lech P, Gnanadurai C, Tesfay M, Buehler J, Suksanpaisan L, Naik S, Brunton B, Recker J, Haselton M, Ziegler C, Roesler A, Mills JR, ... ... Russell SJ, et al. Development and validation of IMMUNO-COV™: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2. Biorxiv : the Preprint Server For Biology. PMID 32577655 DOI: 10.1101/2020.05.26.117549  0.08
2017 Muchtar E, Dispenzieri A, Lacy MQ, Buadi FK, Kapoor P, Hayman SR, Gonsalves W, Warsame R, Kourelis TV, Chakraborty R, Russell S, Lust JA, Lin Y, Go RS, Zeldenrust S, et al. Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation. British Journal of Haematology. PMID 28699650 DOI: 10.1111/Bjh.14830  0.08
2021 Lewis GA, Dodd S, Clayton D, Bedson E, Eccleson H, Schelbert EB, Naish JH, Jimenez BD, Williams SG, Cunnington C, Ahmed FZ, Cooper A, Rajavarma Viswesvaraiah, Russell S, McDonagh T, et al. Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial. Nature Medicine. PMID 34385704 DOI: 10.1038/s41591-021-01452-0  0.079
2013 Ghimire KB, Rajkumar V, Dispenzieri A, Lacy M, Gertz M, Buadi F, Dingli D, Hayman SR, Leung N, Russell S, Lust JA, Zeldenrust SR, Lin Y, Kapoor P, McCurdy AR, et al. Implications of rapidity of response to initial therapy in multiple myeloma. Journal of Clinical Oncology. 31: 8606-8606. DOI: 10.1200/jco.2013.31.15_suppl.8606  0.079
1997 Ager S, Nilson BH, Morling FJ, Peng KW, Cosset FL, Russell SJ. Retroviral display of antibody fragments; interdomain spacing strongly influences vector infectivity. Human Gene Therapy. 7: 2157-64. PMID 8934229 DOI: 10.1089/HUM.1996.7.17-2157  0.079
1995 Cosset FL, Morling FJ, Takeuchi Y, Weiss RA, Collins MK, Russell SJ. Retroviral retargeting by envelopes expressing an N-terminal binding domain. Journal of Virology. 69: 6314-22. PMID 7666532 DOI: 10.1128/JVI.69.10.6314-6322.1995  0.079
2018 Suksanpaisan L, Xu R, Tesfay MZ, Bomidi C, Hamm S, Vandergaast R, Jenks N, Steele MB, Ota-Setlik A, Akhtar H, Luckay A, Nowak R, Peng KW, Eldridge JH, Clarke DK, ... Russell SJ, et al. Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPV Cancers. Molecular Therapy Oncolytics. 10: 1-13. PMID 29998190 DOI: 10.1016/J.Omto.2018.05.001  0.079
2011 Glavey SV, Dispenzieri A, Gertz MA, Kumar S, Lacy MQ, Buadi FK, Rajkumar SV, Hayman SR, Lust JA, Russell SJ, Zeldenrust SR, Dingli D, Hall RL, Leung N. The Depth of Renal Response Strongly Predicts Overall Surival in Patients with AL Amyloidosis Blood. 118: 2868-2868. DOI: 10.1182/Blood.V118.21.2868.2868  0.079
2015 Russell S, Hauert S, Altman R, Veloso M. Robotics: Ethics of artificial intelligence Nature. 521: 415-418. PMID 26017428 DOI: 10.1038/521415a  0.079
2013 Ayala-Breton C, Suksanpaisan L, Mader EK, Russell SJ, Peng KW. Amalgamating oncolytic viruses to enhance their safety, consolidate their killing mechanisms, and accelerate their spread. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1930-7. PMID 23842448 DOI: 10.1038/mt.2013.164  0.079
2015 Ayala Breton C, Wikan N, Abbuhl A, Smith DR, Russell SJ, Peng KW. Oncolytic potency of HER-2 retargeted VSV-FH hybrid viruses: the role of receptor ligand affinity. Molecular Therapy Oncolytics. 2: 15012. PMID 27119107 DOI: 10.1038/mto.2015.12  0.079
2011 Lacy MQ, LaPlant BR, Laumann K, Gertz MA, Hayman SR, Buadi FK, Dispenzieri A, Kumar S, Lust JA, Russell S, Dingli D, Zeldenrust SR, Greipp PR, Fonseca R, Bergsagel P, et al. Pomalidomide and Dexamethasone in Relapsed Myeloma: Results of 225 Patients Treated in Five Cohorts Over Three Years, Blood. 118: 3963-3963. DOI: 10.1182/Blood.V118.21.3963.3963  0.079
2019 Vandergaast R, Khongwichit S, Jiang H, DeGrado TR, Peng KW, Smith DR, Russell SJ, Suksanpaisan L. Enhanced noninvasive imaging of oncology models using the NIS reporter gene and bioluminescence imaging. Cancer Gene Therapy. PMID 30674994 DOI: 10.1038/S41417-019-0081-2  0.079
2013 Mader EK, Butler G, Dowdy SC, Mariani A, Knutson KL, Federspiel MJ, Russell SJ, Galanis E, Dietz AB, Peng KW. Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer. Journal of Translational Medicine. 11: 20. PMID 23347343 DOI: 10.1186/1479-5876-11-20  0.079
2010 Kumar S, Dispenzieri A, Lacy M, Hayman SR, Buadi F, Dingli D, Detweiler-Short K, Lust J, Zeldenrust S, Russell S, Greipp PR, Kyle R, Gertz M, Rajkumar V. Improvement In Renal Function In Newly Diagnosed Myeloma Improves Survival, but Still Remains Inferior to Those with Normal Renal Function Blood. 116: 2970-2970. DOI: 10.1182/BLOOD.V116.21.2970.2970  0.078
2004 Dingli D, Russell SJ, Morris JC. In vivo imaging and tumor therapy with the sodium iodide symporter. Journal of Cellular Biochemistry. 90: 1079-86. PMID 14635183 DOI: 10.1002/Jcb.10714  0.078
2009 Peng KW, Dogan A, Vrana J, Liu C, Ong HT, Kumar S, Dispenzieri A, Dietz AB, Russell SJ. Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma. American Journal of Hematology. 84: 401-7. PMID 19507209 DOI: 10.1002/ajh.21444  0.078
2001 Galanis E, Bateman A, Johnson K, Diaz RM, James CD, Vile R, Russell SJ. Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas. Human Gene Therapy. 12: 811-21. PMID 11339897 DOI: 10.1089/104303401750148766  0.078
2007 Russell SJ, Peng KW. Viruses as anticancer drugs. Trends in Pharmacological Sciences. 28: 326-33. PMID 17573126 DOI: 10.1016/J.TIPS.2007.05.005  0.078
2010 Penheiter AR, Wegman TR, Classic KL, Dingli D, Bender CE, Russell SJ, Carlson SK. Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer. Ajr. American Journal of Roentgenology. 195: 341-9. PMID 20651188 DOI: 10.2214/AJR.09.3672  0.078
2017 Tandon N, Sidana S, Dispenzieri A, Gertz MA, Lacy M, Dingli D, Buadi F, Fonder AL, Hayman SR, Hwa YL, Hobbs MA, Kapoor P, Gonsalves WI, Leung N, Go RS, ... ... Russell SJ, et al. Outcomes according to involved free light chain (FLC) levels in patients with normal FLC ratio after initial therapy in light chain amyloidosis (AL). Journal of Clinical Oncology. 35: 8049-8049. DOI: 10.1200/Jco.2017.35.15_Suppl.8049  0.078
2003 Khare PD, Russell SJ, Federspiel MJ. Avian leukosis virus is a versatile eukaryotic platform for polypeptide display. Virology. 315: 303-12. PMID 14585333 DOI: 10.1016/S0042-6822(03)00529-4  0.078
2007 Russell SJ, Dogan A, Ong HT, Vrana J, Dispenzieri A, Dietz AB, Peng K. Tumor Associated Macrophages (TAM) in Skeletal Plasmacytomas of Patients with Multiple Myeloma. Blood. 110: 114-114. DOI: 10.1182/BLOOD.V110.11.114.114  0.078
2018 Muchtar E, Dispenzieri A, Leung N, Lacy MQ, Buadi FK, Dingli D, Grogan M, Hayman SR, Kapoor P, Hwa YL, Fonder A, Hobbs M, Chakraborty R, Gonsalves W, Kourelis TV, ... ... Russell S, et al. Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria. Leukemia. PMID 29581546 DOI: 10.1038/S41375-018-0060-X  0.078
2015 Gertz MA, Lacy M, Dispenzieri A, Buadi F, Dingli D, Hayman SR, Kumar S, Leung N, Lust JA, Rajkumar SV, Russell SJ, Suman V, Hogan WJ. Phase III trial of stem cell transplantation compared to melphalan and dexamethasone in the treatment of immunoglobulin light chain amyloidosis (AL). Journal of Clinical Oncology. 33: 8595-8595. DOI: 10.1200/Jco.2015.33.15_Suppl.8595  0.078
2010 Reinholz MM, Zinnen SP, Dueck AC, Dingli D, Reinholz GG, Jonart LA, Kitzmann KA, Bruzek AK, Negron V, Abdalla AK, Arendt BK, Croatt AJ, Sanchez-Perez L, Sebesta DP, Lönnberg H, ... ... Russell SJ, et al. A promising approach for treatment of tumor-induced bone diseases: utilizing bisphosphonate derivatives of nucleoside antimetabolites. Bone. 47: 12-22. PMID 20233612 DOI: 10.1016/J.Bone.2010.03.006  0.077
2015 Kyoung M, Russell SJ, Kohnhorst CL, Esemoto NN, An S. Dynamic architecture of the purinosome involved in human de novo purine biosynthesis. Biochemistry. 54: 870-80. PMID 25540829 DOI: 10.1021/Bi501480D  0.077
2018 Gladden J, Guenzel A, Behfar A, Moulay G, Fayyaz A, Chaanine A, Russell S, Redfield M. Cardiac Specific Gene Delivery of the Natriuretic Peptide Receptor Improves Diastolic Function in a Canine Model of HFpEF. Journal of Cardiac Failure. 24: S35-S36. DOI: 10.1016/J.Cardfail.2018.07.104  0.077
2015 Kourelis TV, Buadi FK, Gertz MA, Lacy MQ, Kumar SK, Kapoor P, Go RS, Lust JA, Hayman SR, Rajkumar V, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Leung N, et al. Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first line treatment. Leukemia. PMID 26669974 DOI: 10.1038/Leu.2015.344  0.077
2015 Miller A, Nace R, Ayala-Breton C C, Steele M, Bailey K, Peng KW, Russell SJ. Perfusion pressure is a critical determinant of the intratumoral extravasation of oncolytic viruses. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26647825 DOI: 10.1038/Mt.2015.219  0.077
2004 Anderson BD, Nakamura T, Russell SJ, Peng KW. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. Cancer Research. 64: 4919-26. PMID 15256464 DOI: 10.1158/0008-5472.CAN-04-0884  0.077
2021 Drosou ME, Vaughan LE, Muchtar E, Buadi FK, Dingli D, Dispenzieri A, Fonder AL, Gertz MA, Go RS, Gonsalves WI, Hayman SR, Hobbs MA, Hwa YL, Kapoor P, Kourelis T, ... ... Russell SJ, et al. Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohort. American Journal of Hematology. PMID 33428787 DOI: 10.1002/ajh.26092  0.077
2019 Binder M, Rajkumar SV, Ketterling RP, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Hayman SR, Hwa YL, Zeldenrust SR, Lust JA, Russell SJ, Leung N, Kapoor P, Go RS, et al. Substratification of patients with newly diagnosed standard-risk multiple myeloma. British Journal of Haematology. PMID 30768679 DOI: 10.1111/Bjh.15800  0.077
2020 Maroun JW, Penza V, Weiskittel TM, Schulze AJ, Russell SJ. Collateral Lethal Effects of Complementary Oncolytic Viruses. Molecular Therapy Oncolytics. 18: 236-246. PMID 32728612 DOI: 10.1016/j.omto.2020.06.017  0.077
2016 Pallante AJ, Leung N, Kyle RA, Tefferi A, Russell SJ, Habermann TM, Lacy MQ, Hayman SR, Al-Kali A, Reeder C, Dispenzieri A, Gertz MA, Buadi FK, Hook CC, Dingli D, et al. Concomitant Myeloproliferative Disorders (MPD) and Amyloidosis Blood. 128: 5480-5480. DOI: 10.1182/BLOOD.V128.22.5480.5480  0.076
2007 Ong HT, Hasegawa K, Dietz AB, Russell SJ, Peng KW. Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies Gene Therapy. 14: 324-333. PMID 17051248 DOI: 10.1038/sj.gt.3302880  0.076
2009 Hummel HD, Kuntz G, Russell SJ, Nakamura T, Greiner A, Einsele H, Topp MS. Genetically engineered attenuated measles virus specifically infects and kills primary multiple myeloma cells. The Journal of General Virology. 90: 693-701. PMID 19218216 DOI: 10.1099/vir.0.007302-0  0.076
2003 Schneider RM, Medvedovska Y, Hartl I, Voelker B, Chadwick MP, Russell SJ, Cichutek K, Buchholz CJ. Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteases. Gene Therapy. 10: 1370-80. PMID 12883534 DOI: 10.1038/sj.gt.3302007  0.076
2005 Hartl I, Schneider RM, Sun Y, Medvedovska J, Chadwick MP, Russell SJ, Cichutek K, Buchholz CJ. Library-based selection of retroviruses selectively spreading through matrix metalloprotease-positive cells. Gene Therapy. 12: 918-26. PMID 15716977 DOI: 10.1038/sj.gt.3302467  0.076
2020 Concilio SC, Suksanpaisan L, Pham L, Peng KW, Russell SJ. Improved Noninvasive In Vivo Tracking of AAV-9 Gene Therapy Using the Perchlorate-Resistant Sodium Iodide Symporter from Minke Whale. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 33038323 DOI: 10.1016/j.ymthe.2020.09.036  0.076
2020 Sakemura R, Eckert EC, Crotts SB, Pham L, Siegler EL, Cox MJ, Tapper EE, Hefazi M, Manriquez Roman C, Schick KJ, Can I, Bezerra ED, Kankeu Fonkoua L, Horvei P, Ruff MW, ... ... Russell SJ, et al. Vesicular Stomatitis Virus (VSV) Engineered to Express CD19 Stimulates Anti-CD19 Chimeric Antigen Receptor Modified T Cells and Promotes Their Anti-Tumor Effects Blood. 136: 30-31. DOI: 10.1182/blood-2020-139647  0.075
1998 Fielding AK, Maurice M, Morling FJ, Cosset F, Russell SJ. Inverse Targeting of Retroviral Vectors: Selective Gene Transfer in a Mixed Population of Hematopoietic and Nonhematopoietic Cells Blood. 91: 1802-1809. DOI: 10.1182/BLOOD.V91.5.1802.1802_1802_1809  0.075
2014 Lacy MQ, LaPlant BR, Laumann KM, Kumar S, Gertz MA, Hayman SR, Buadi F, Dispenzieri A, Lust JA, Kapoor P, Leung N, Russell S, Dingli D, Go RS, Gonsalves WI, et al. Pomalidomide Plus Low-Dose Dexamethasone (Pom/Dex) in Relapsed Lenalidomide Refractory Myeloma: Long Term Follow up and Comparison of 2 Mg Vs 4 Mg Doses Blood. 124: 4780-4780. DOI: 10.1182/Blood.V124.21.4780.4780  0.075
2007 Paraskevakou G, Allen C, Nakamura T, Zollman P, James CD, Peng KW, Schroeder M, Russell SJ, Galanis E. Epidermal growth factor receptor (EGFR)-retargeted measles virus strains effectively target EGFR- or EGFRvIII expressing gliomas. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 677-86. PMID 17299404 DOI: 10.1038/sj.mt.6300105  0.075
2018 Russell SJ, Barber GN. Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines. Cancer Cell. 33: 599-605. PMID 29634947 DOI: 10.1016/J.Ccell.2018.03.011  0.075
2016 Binder M, Rajkumar SV, Ketterling RP, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Hayman SR, Hwa YL, Zeldenrust SR, Lust JA, Russell SJ, Leung N, Kapoor P, Go RS, et al. Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma Blood Cancer Journal. 6. DOI: 10.1038/bcj.2016.15  0.075
2012 Ayala-Breton C, Barber GN, Russell SJ, Peng KW. Retargeting vesicular stomatitis virus using measles virus envelope glycoproteins. Human Gene Therapy. 23: 484-91. PMID 22171635 DOI: 10.1089/Hum.2011.146  0.075
1999 Hatziioannou T, Delahaye E, Martin F, Russell SJ, Cosset FL. Retroviral display of functional binding domains fused to the amino terminus of influenza hemagglutinin. Human Gene Therapy. 10: 1533-44. PMID 10395378 DOI: 10.1089/10430349950017860  0.074
2021 Nandakumar B, Kumar SK, Dispenzieri A, Buadi FK, Dingli D, Lacy MQ, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Muchtar E, Warsame R, Kourelis TV, ... Russell S, et al. Clinical Characteristics and Outcomes of Patients With Primary Plasma Cell Leukemia in the Era of Novel Agent Therapy. Mayo Clinic Proceedings. 96: 677-687. PMID 33673918 DOI: 10.1016/j.mayocp.2020.06.060  0.074
2014 Suksanpaisan L, Russell SJ, Peng KW. High scFv-receptor affinity does not enhance the antitumor activity of HER2-retargeted measles virus. Cancer Gene Therapy. 21: 256-60. PMID 24874841 DOI: 10.1038/cgt.2014.25  0.074
2018 Binder M, Rajkumar SV, Lacy MQ, Gertz MA, Buadi FK, Dispenzieri A, Hwa L, Fonder A, Hobbs M, Hayman SR, Zeldenrust SR, Lust JA, Russell SJ, Leung N, Kapoor P, et al. Peripheral Blood Biomarkers of Early Immune Reconstitution in Newly Diagnosed Multiple Myeloma. American Journal of Hematology. PMID 30516847 DOI: 10.1002/Ajh.25365  0.074
1997 Valsesia-Wittmann S, Morling FJ, Hatziioannou T, Russell SJ, Cosset FL. Receptor co-operation in retrovirus entry: recruitment of an auxiliary entry mechanism after retargeted binding. The Embo Journal. 16: 1214-23. PMID 9135138 DOI: 10.1093/emboj/16.6.1214  0.074
2015 Russell SJ. Progress of artificial pancreas devices towards clinical use: the first outpatient studies. Current Opinion in Endocrinology, Diabetes, and Obesity. 22: 106-11. PMID 25692927 DOI: 10.1097/MED.0000000000000142  0.074
2016 Zhang L, Steele MB, Jenks N, Grell J, Behrens M, Nace R, Naik S, Federspiel MJ, Russell SJ, Peng KW. Robust oncolytic virotherapy induces tumor lysis syndrome and associated toxicities in the MPC-11 plasmacytoma model. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 27669655 DOI: 10.1038/mt.2016.167  0.074
2011 Siragusa S, Morice W, Gertz MA, Kyle RA, Greipp PR, Lust JA, Witzig TE, Lacy MQ, Zeldenrust SR, Rajkumar SV, Russell SJ, Hayman SR, Buadi F, Kumar SK, Dingli D, et al. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature. Annals of Hematology. 90: 101-6. PMID 20645101 DOI: 10.1007/S00277-010-1028-8  0.074
2019 Lakshman A, Painuly U, Rajkumar SV, Ketterling RP, Kapoor P, Greipp PT, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Dispenzieri A, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, ... ... Russell SJ, et al. Natural history of multiple myeloma with de novo del(17p). Blood Cancer Journal. 9: 32. PMID 30846679 DOI: 10.1038/S41408-019-0191-Y  0.074
2009 Ong HT, Trejo TR, Pham LD, Oberg AL, Russell SJ, Peng KW. Intravascularly administered RGD-displaying measles viruses bind to and infect neovessel endothelial cells in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1012-21. PMID 19277014 DOI: 10.1038/mt.2009.39  0.074
2008 Galanis E, Hartmann LC, Cliby W, Peethambaram PP, Long HJ, Kaur JS, Haluska P, Sloan JA, Peng K, Russell SJ. Phase I trial of Intraperitoneal (IP) administration of a measles virus (MV) derivative expressing the human carcinoembryonic antigen (CEA) in recurrent ovarian cancer (OvCa). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 5538. PMID 27950491 DOI: 10.1200/jco.2008.26.15_suppl.5538  0.074
2006 Allen C, Vongpunsawad S, Nakamura T, James CD, Schroeder M, Cattaneo R, Giannini C, Krempski J, Russell SJ, Galanis E. 430. EGFRvIII Retargeted Oncolytic Measles Virus Strains Have Significant Antitumor Activity Against Gliomas Molecular Therapy. 13: S165-S166. DOI: 10.1016/J.Ymthe.2005.07.260  0.073
2006 Hasegawa K, Pham L, O'Connor MK, Federspiel MJ, Russell SJ, Peng KW. Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 1868-75. PMID 16551872 DOI: 10.1158/1078-0432.CCR-05-1803  0.073
2003 Russell SJ, Peng KW. Primer on medical genomics. Part X: Gene therapy. Mayo Clinic Proceedings. 78: 1370-83. PMID 14601696 DOI: 10.4065/78.11.1370  0.073
2009 Carlson SK, Classic KL, Hadac EM, Dingli D, Bender CE, Kemp BJ, Russell SJ. Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene. Ajr. American Journal of Roentgenology. 192: 279-87. PMID 19098211 DOI: 10.2214/AJR.08.1205  0.073
2016 Muchtar E, Derudas D, Mauermann M, Liewluck T, Dispenzieri A, Kumar SK, Dingli D, Lacy MQ, Buadi FK, Hayman SR, Kapoor P, Leung N, Chakraborty R, Gonsalves W, Russell S, et al. Systemic Immunoglobulin Light Chain Amyloidosis-Associated Myopathy: Presentation, Diagnostic Pitfalls, and Outcome. Mayo Clinic Proceedings. 91: 1354-1361. PMID 27712634 DOI: 10.1016/j.mayocp.2016.06.027  0.073
2010 Kelly EJ, Nace R, Barber GN, Russell SJ. Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting. Journal of Virology. 84: 1550-62. PMID 19906911 DOI: 10.1128/Jvi.01788-09  0.073
2014 Podetz-Pedersen KM, Vezys V, Somia NV, Russell SJ, McIvor RS. Cellular immune response against firefly luciferase after sleeping beauty-mediated gene transfer in vivo. Human Gene Therapy. 25: 955-65. PMID 25093708 DOI: 10.1089/Hum.2014.048  0.073
2015 Miller AC, Nace R, Suksanpaisan L, Peng K, Russell SJ. 429. Optimizing Intratumoral Oncolytic Virus Delivery Using Hemodynamic Manipulations Molecular Therapy. 23: S169-S170. DOI: 10.1016/S1525-0016(16)34038-2  0.073
2015 Milani P, Buadi F, Gertz M, Merlini G, Lacy M, Palladini G, Lust J, Dingli D, Go R, Kumar S, Leung N, Hayman S, Hwa L, Kapoor P, Kyle R, ... ... Russell S, et al. A simple model to predict survival using age, comorbidities and functional status in patients with multiple myeloma (MM) Clinical Lymphoma Myeloma and Leukemia. 15: e94-e95. DOI: 10.1016/j.clml.2015.07.257  0.073
2014 Kobashigawa J, Zuckermann A, Macdonald P, Leprince P, Esmailian F, Luu M, Mancini D, Patel J, Razi R, Reichenspurner H, Russell S, Segovia J, Smedira N, Stehlik J, Wagner F, et al. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 33: 327-40. PMID 24661451 DOI: 10.1016/J.Healun.2014.02.027  0.073
2007 Doyle B, Kemp BJ, Chareonthaitawee P, Reed C, Schmeckpeper J, Sorajja P, Russell S, Araoz P, Riederer SJ, Caplice NM. Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 1708-14. PMID 17909258 DOI: 10.2967/Jnumed.107.042838  0.073
2013 Geng L, Gao Y, Chen X, Hou S, Zhan CG, Radic Z, Parks RJ, Russell SJ, Pham L, Brimijoin S. Gene transfer of mutant mouse cholinesterase provides high lifetime expression and reduced cocaine responses with no evident toxicity. Plos One. 8: e67446. PMID 23840704 DOI: 10.1371/journal.pone.0067446  0.073
1992 Russell SJ, Llewelyn MB, Hawkins RE. Principles of antibody therapy British Medical Journal. 305: 1424-1429. PMID 1486312 DOI: 10.1136/bmj.305.6866.1424  0.072
2014 Kumar AH, Martin K, Doyle B, Huang CL, Pillai GK, Ali MT, Skelding KA, Wang S, Gleeson BM, Jahangeer S, Ritman EL, Russell SJ, Caplice NM. Intravascular cell delivery device for therapeutic VEGF-induced angiogenesis in chronic vascular occlusion. Biomaterials. 35: 9012-22. PMID 25096850 DOI: 10.1016/j.biomaterials.2014.07.016  0.072
2014 Liu YP, Steele MB, Suksanpaisan L, Federspiel MJ, Russell SJ, Peng KW, Bakkum-Gamez JN. Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancer. Gynecologic Oncology. 132: 194-202. PMID 24246772 DOI: 10.1016/j.ygyno.2013.11.010  0.072
2017 Sidana S, Tandon N, Dispenzieri A, Gertz MA, Buadi F, Lacy M, Dingli D, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Hwa YL, Kapoor P, Kyle RA, Leung N, ... ... Russell SJ, et al. Factors predicting organ response in light chain amyloidosis (AL). Journal of Clinical Oncology. 35: 8048-8048. DOI: 10.1200/Jco.2017.35.15_Suppl.8048  0.072
2017 Tandon N, Rajkumar SV, LaPlant B, Pettinger A, Lacy MQ, Dispenzieri A, Buadi FK, Gertz MA, Hayman SR, Leung N, Go RS, Dingli D, Kapoor P, Lin Y, Hwa YL, ... ... Russell SJ, et al. Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma. Blood Cancer Journal. 7: e528. PMID 28211889 DOI: 10.1038/bcj.2017.13  0.071
2009 Lacy MQ, Hayman SR, Gertz MA, Dispenzieri A, Buadi F, Kumar S, Greipp PR, Lust JA, Russell SJ, Dingli D, Kyle RA, Fonseca R, Bergsagel PL, Roy V, Mikhael JR, et al. Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5008-14. PMID 19720894 DOI: 10.1200/Jco.2009.23.6802  0.071
2005 Dwyer RM, Schatz SM, Bergert ER, Myers RM, Harvey ME, Classic KL, Blanco MC, Frisk CS, Marler RJ, Davis BJ, O'Connor MK, Russell SJ, Morris JC. A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancer Molecular Therapy. 12: 835-841. PMID 16054438 DOI: 10.1016/J.Ymthe.2005.05.013  0.071
2008 Miyagi N, Rao VP, Ricci D, Du Z, Byrne GW, Bailey KR, Nakai H, Russell SJ, McGregor CGA. Efficient and Durable Gene Transfer to Transplanted Heart Using Adeno-associated Virus 9 Vector Journal of Heart and Lung Transplantation. 27: 554-560. PMID 18442723 DOI: 10.1016/J.Healun.2008.01.025  0.071
2008 Rao VP, Branzoli SE, Ricci D, Miyagi N, O'Brien T, Tazelaar HD, Russell SJ, McGregor CG. Recombinant adenoviral gene transfer does not affect cardiac allograft vasculopathy. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 26: 1281-5. PMID 18096479 DOI: 10.1016/J.HEALUN.2007.09.018  0.071
2020 Muchtar E, Gertz MA, Kumar SK, Lacy MQ, Leung N, Buadi FK, Dingli D, Hayman SR, Go RS, Kapoor P, Gonsalves W, Kourelis TV, Warsame R, Hwa YL, Fonder A, ... ... Russell S, et al. Characterization and prognostic implication of delayed complete response in AL amyloidosis. European Journal of Haematology. PMID 33230879 DOI: 10.1111/ejh.13554  0.071
2006 Ong HT, Timm MM, Greipp PR, Witzig TE, Dispenzieri A, Russell SJ, Peng KW. Oncolytic measles virus targets high CD46 expression on multiple myeloma cells Experimental Hematology. 34: 713-720. PMID 16728275 DOI: 10.1016/j.exphem.2006.03.002  0.071
2014 Sageman-Furnas AO, Goswami P, Menon G, Russell SJ. The Sphereprint: An approach to quantifying the conformability of flexible materials Textile Research Journal. 84: 793-807. DOI: 10.1177/0040517513512402  0.071
2010 Dingli D, Buadi F, Dispenzieri A, Hayman S, Kumar S, Lacy M, Russell S, Rajkumar SV, Gertz MA. Depth of response with stem cell transplantation and outcome for multiple myeloma in the era of novel agents F1000research. 1. DOI: 10.7490/F1000Research.140.1  0.071
2018 Muñoz-Alía MÁ, Muller CP, Russell SJ. Hemagglutinin-specific neutralization of subacute sclerosing panencephalitis viruses. Plos One. 13: e0192245. PMID 29466428 DOI: 10.1371/journal.pone.0192245  0.071
2018 Lakshman A, Painuly U, Rajkumar SV, Dispenzieri A, Gertz MA, Buadi F, Lacy M, Dingli D, Hayman SR, Kourelis T, Warsame RM, Gonsalves WI, Kapoor P, Leung N, Go RS, ... ... Russell SJ, et al. Natural history of delp53 multiple myeloma. Journal of Clinical Oncology. 36: e20017-e20017. DOI: 10.1200/Jco.2018.36.15_Suppl.E20017  0.071
2016 Hwa YL, Shi Q, Kumar SK, Lacy MQ, Gertz MA, Kapoor P, Buadi FK, Leung N, Dingli D, Go RS, Hayman SR, Gonsalves WI, Russell S, Lust JA, Lin Y, et al. Beta-blockers Improve Survival Outcomes in Patients with Multiple Myeloma: A Retrospective Evaluation. American Journal of Hematology. PMID 27733010 DOI: 10.1002/Ajh.24582  0.07
2011 Cataliotti A, Tonne JM, Bellavia D, Martin FL, Oehler EA, Harders GE, Campbell JM, Peng KW, Russell SJ, Malatino LS, Burnett JC, Ikeda Y. Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats. Circulation. 123: 1297-305. PMID 21403100 DOI: 10.1161/Circulationaha.110.981720  0.07
2006 Ong HT, Hasegawa K, Harvey M, Dietz A, Russell SJ, Peng K. 482. T Cells as Carriers for Systemic Measles Virotherapy of Multiple Myeloma Molecular Therapy. 13: S187. DOI: 10.1016/J.YMTHE.2006.08.551  0.07
2004 Dingli DM, Bergert ER, Bajzer Ž, O'Connor MK, Russell SJ, Morris JC. Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporter. Biochemical and Biophysical Research Communications. 325: 157-166. PMID 15522214 DOI: 10.1016/J.Bbrc.2004.09.219  0.07
2024 Elsaid A, Egdell R, Singh V, Russell S. Interesting case of regional left ventricular hypertrophy. Bmj Case Reports. 17. PMID 38490700 DOI: 10.1136/bcr-2023-257882  0.07
2009 Frecha C, Costa C, Lévy C, Nègre D, Russell SJ, Maisner A, Salles G, Peng KW, Cosset FL, Verhoeyen E. Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors. Blood. 114: 3173-80. PMID 19667401 DOI: 10.1182/blood-2009-05-220798  0.07
2013 Suksanpaisan L, Pham L, McIvor S, Russell SJ, Peng KW. Oral contrast enhances the resolution of in-life NIS reporter gene imaging. Cancer Gene Therapy. 20: 638-41. PMID 24030210 DOI: 10.1038/cgt.2013.57  0.07
2006 Dingli D, Kemp BJ, O'Connor MK, Morris JC, Russell SJ, Lowe VJ. Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor. Molecular Imaging and Biology. 8: 16-23. PMID 16328647 DOI: 10.1007/S11307-005-0025-0  0.07
2012 Penheiter AR, Griesmann GE, Federspiel MJ, Dingli D, Russell SJ, Carlson SK. Pinhole micro-SPECT/CT for noninvasive monitoring and quantitation of oncolytic virus dispersion and percent infection in solid tumors. Gene Therapy. 19: 279-87. PMID 21753796 DOI: 10.1038/gt.2011.107  0.07
2009 Mader EK, Maeyama Y, Lin Y, Butler GW, Russell HM, Galanis E, Russell SJ, Dietz AB, Peng KW. Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 7246-55. PMID 19934299 DOI: 10.1158/1078-0432.CCR-09-1292  0.07
2019 Muchtar E, Dispenzieri A, Leung N, Lacy MQ, Buadi FK, Dingli D, Grogan M, Hayman SR, Kapoor P, Hwa YL, Fonder A, Hobbs M, Chakraborty R, Gonsalves W, Kourelis TV, ... ... Russell S, et al. Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 26: 101-102. PMID 31343331 DOI: 10.1080/13506129.2019.1582486  0.07
2020 Muchtar E, Gertz MA, Lacy MQ, Leung N, Buadi FK, Dingli D, Hayman SR, Go RS, Kapoor P, Gonsalves W, Kourelis TV, Warsame R, Hwa YL, Fonder A, Hobbs M, ... Russell S, et al. Refining amyloid complete hematological response: quantitative serum free light chains superior to ratio. American Journal of Hematology. PMID 32681737 DOI: 10.1002/Ajh.25940  0.069
2002 Peng KW, Facteau S, Wegman T, O'Kane D, Russell SJ. Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides. Nature Medicine. 8: 527-31. PMID 11984600 DOI: 10.1038/nm0502-527  0.069
2007 Bryce AH, Ketterling R, Gertz M, Zeldenrust S, Lacy M, Kumar S, Hayman S, Buadi F, Greipp P, Lust J, Rajkumar V, Fonseca R, Dingli D, Russell S, Kyle R, et al. 14q32 Abnormalities and 13q Deletions Are Common in Primary Systemic Amyloidosis Using Cytoplasmic Immunoglobulin Fluorescence In Situ Hybridization (cIg-FISH). Blood. 110: 2477-2477. DOI: 10.1182/BLOOD.V110.11.2477.2477  0.069
2019 Gonsalves WI, Jevremovic D, Nandakumar B, Dispenzieri A, Buadi FK, Dingli D, Lacy MQ, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Muchtar E, Warsame R, ... ... Russell S, et al. Enhancing the R-ISS Classification of Newly Diagnosed Multiple Myeloma by Quantifying Circulating Clonal Plasma Cells. American Journal of Hematology. PMID 31867775 DOI: 10.1002/Ajh.25709  0.069
2005 Dingli D, Peng KW, Harvey ME, Vongpunsawad S, Bergert ER, Kyle RA, Cattaneo R, Morris JC, Russell SJ. Interaction of measles virus vectors with Auger electron emitting radioisotopes. Biochemical and Biophysical Research Communications. 337: 22-9. PMID 16171777 DOI: 10.1016/J.Bbrc.2005.08.261  0.069
2016 Podetz-Pedersen KM, Olson ER, Somia NV, Russell SJ, McIvor RS. A Broad Range of Dose Optima Achieve High-level, Long-term Gene Expression After Hydrodynamic Delivery of Sleeping Beauty Transposons Using Hyperactive SB100x Transposase. Molecular Therapy. Nucleic Acids. 5: e279. PMID 26784638 DOI: 10.1038/Mtna.2015.54  0.069
2013 Kourelis T, Gertz M, Lacy M, Buadi F, Hayman SR, Kumar S, Zeldenrust SR, Leung N, Kyle RA, Russell S, Dingli D, Lust JA, Lin Y, Kapoor P, Rajkumar V, et al. Definition of a high-risk population among patients with AL amyloidosis not undergoing autologous stem cell transplantation using bone marrow plasmacytosis and the presence of CRAB. Journal of Clinical Oncology. 31: 8516-8516. DOI: 10.1200/jco.2013.31.15_suppl.8516  0.069
1998 Buchholz CJ, Peng KW, Morling FJ, Zhang J, Cosset FL, Russell SJ. In vivo selection of protease cleavage sites from retrovirus display libraries. Nature Biotechnology. 16: 951-4. PMID 9788352 DOI: 10.1038/nbt1098-951  0.069
2003 Khare PD, Rosales AG, Bailey KR, Russell SJ, Federspiel MJ. Epitope selection from an uncensored peptide library displayed on avian leukosis virus. Virology. 315: 313-321. PMID 14585334 DOI: 10.1016/S0042-6822(03)00530-0  0.068
2011 Hadac EM, Federspiel MJ, Chernyy E, Tuzikov A, Korchagina E, Bovin NV, Russell S, Henry SM. Fluorescein and radiolabeled Function-Spacer-Lipid constructs allow for simple in vitro and in vivo bioimaging of enveloped virions. Journal of Virological Methods. 176: 78-84. PMID 21703308 DOI: 10.1016/j.jviromet.2011.06.005  0.068
2013 Lech PJ, Tobin GJ, Bushnell R, Gutschenritter E, Pham LD, Nace R, Verhoeyen E, Cosset FL, Muller CP, Russell SJ, Nara PL. Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodies. Plos One. 8: e52306. PMID 23300970 DOI: 10.1371/journal.pone.0052306  0.068
2010 Bera S, Greiner S, Choudhury A, Dispenzieri A, Spitz DR, Russell SJ, Goel A. Dexamethasone-induced oxidative stress enhances myeloma cell radiosensitization while sparing normal bone marrow hematopoiesis. Neoplasia (New York, N.Y.). 12: 980-92. PMID 21170263 DOI: 10.1593/Neo.101146  0.068
2015 Naik S, Leblanc AK, Galyon G, Frazier S, Jenks N, Steele M, Miller A, Whye Peng K, Federspiel M, Russell SJ. 70. Safety, Toxicity and Efficacy of Systemic Recombinant VSV Therapy in Pet Dogs With Spontaneous Cancer Molecular Therapy. 23: S30-S31. DOI: 10.1016/S1525-0016(16)33675-9  0.067
2021 Muñoz-Alía MÁ, Nace RA, Zhang L, Russell SJ. Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface glycoproteins. Cell Reports. Medicine. 2: 100225. PMID 33948566 DOI: 10.1016/j.xcrm.2021.100225  0.067
2003 Peng KW, Donovan KA, Schneider U, Cattaneo R, Lust JA, Russell SJ. Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker. Blood. 101: 2557-62. PMID 12433686 DOI: 10.1182/Blood-2002-07-2195  0.067
2013 Kapoor P, Kumar SK, Dispenzieri A, Lacy MQ, Buadi F, Dingli D, Russell SJ, Hayman SR, Witzig TE, Lust JA, Leung N, Lin Y, Zeldenrust SR, McCurdy A, Greipp PR, et al. Importance of achieving stringent complete response after autologous stem-cell transplantation in multiple myeloma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 4529-35. PMID 24248686 DOI: 10.1200/Jco.2013.49.0086  0.067
2006 Merchan JR, Tang J, Hu G, Lin Y, Mutter W, Tong C, Karumanchi SA, Russell SJ, Sukhatme VP. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model. Journal of the National Cancer Institute. 98: 756-64. PMID 16757700 DOI: 10.1093/jnci/djj208  0.067
2011 Frecha C, Lévy C, Costa C, Nègre D, Amirache F, Buckland R, Russell SJ, Cosset FL, Verhoeyen E. Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors. Journal of Virology. 85: 5975-85. PMID 21450813 DOI: 10.1128/JVI.00324-11  0.067
2020 Sakemura R, Suksanpaisan L, Khadka RH, Newsom AN, Hansen MJ, Hefazi M, Roman CM, Schick KJ, Tapper EE, Horvei P, Ruff MW, Parikh SA, Kay NE, Ruff KM, Russell SJ, et al. Development of a Sensitive and Efficient Reporter Platform for the Detection of Chimeric Antigen Receptor T Cell Expansion, Trafficking, and Toxicity Biology of Blood and Marrow Transplantation. 26: S256-S257. DOI: 10.1016/j.bbmt.2019.12.450  0.067
2011 Lacy MQ, Allred JB, Gertz MA, Hayman SR, Short KD, Buadi F, Dispenzieri A, Kumar S, Greipp PR, Lust JA, Russell SJ, Dingli D, Zeldenrust S, Fonseca R, Bergsagel PL, et al. Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease. Blood. 118: 2970-5. PMID 21690557 DOI: 10.1182/Blood-2011-04-348896  0.067
1993 Hawkins RE, Winter G, Hamblin TJ, Stevenson FK, Russell SJ. A genetic approach to idiotypic vaccination Journal of Immunotherapy. 14: 273-278. PMID 8280708 DOI: 10.1097/00002371-199311000-00004  0.066
2001 Pham L, Ye H, Cosset FL, Russell SJ, Peng KW. Concentration of viral vectors by co-precipitation with calcium phosphate. The Journal of Gene Medicine. 3: 188-94. PMID 11318118 DOI: 10.1002/1521-2254(2000)9999:9999<::AID-JGM159>3.0.CO;2-9  0.066
2014 Käse SK, Russell SJ. Modes of hole formation in long-lasting insecticidal nets (LLINs) retrieved from South Eastern Ghana. Parasites & Vectors. 7: 547. PMID 25476877 DOI: 10.1186/s13071-014-0547-x  0.066
2017 Miller A, Asmann Y, Cattaneo L, Braggio E, Keats J, Auclair D, Lonial S, Russell SJ, Stewart AK. High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma. Blood Cancer Journal. 7: e612. PMID 28937974 DOI: 10.1038/Bcj.2017.94  0.066
2005 Nakamura T, Peng KW, Harvey M, Greiner S, Lorimer IA, James CD, Russell SJ. Rescue and propagation of fully retargeted oncolytic measles viruses. Nature Biotechnology. 23: 209-14. PMID 15685166 DOI: 10.1038/nbt1060  0.066
2015 Stalker L, Russell SJ, Co C, Foster RA, LaMarre J. PIWIL1 Is Expressed in the Canine Testis, Increases with Sexual Maturity, and Binds Small RNAs. Biology of Reproduction. PMID 26658707 DOI: 10.1095/Biolreprod.115.131854  0.065
2002 Lavillette D, Russell SJ, Cosset FL. Retargeting gene delivery using surface-engineered retroviral vector particles. Current Opinion in Biotechnology. 12: 461-6. PMID 11604321 DOI: 10.1016/S0958-1669(00)00246-9  0.065
2015 Wiedemann SG, Ledgard SF, Henry BK, Yan MJ, Mao N, Russell SJ. Application of life cycle assessment to sheep production systems: investigating co-production of wool and meat using case studies from major global producers International Journal of Life Cycle Assessment. 20: 463-476. DOI: 10.1007/s11367-015-0849-z  0.065
2009 Schmeckpeper J, Ikeda Y, Kumar AH, Metharom P, Russell SJ, Caplice NM. Lentiviral tracking of vascular differentiation in bone marrow progenitor cells. Differentiation; Research in Biological Diversity. 78: 169-76. PMID 19715661 DOI: 10.1016/J.Diff.2009.01.002  0.065
2019 Muñoz-Alía MA, Russell SJ. Probing Morbillivirus Antisera Neutralization Using Functional Chimerism between Measles Virus and Canine Distemper Virus Envelope Glycoproteins. Viruses. 11. PMID 31357579 DOI: 10.3390/v11080688  0.065
2016 Miller A, Cattaneo L, Asmann YW, Braggio E, Keats JJ, Auclair D, Lonial S, Russell SJ, Stewart AK. Correlation Between Somatic Mutation Burden, Neoantigen Load and Progression Free Survival in Multiple Myeloma: Analysis of MMRF CoMMpass Study Blood. 128: 193-193. DOI: 10.1182/Blood.V128.22.193.193  0.065
1999 Alvarez-Vallina L, Russell SJ. Efficient discrimination between different densities of target antigen by tetracycline-regulatable T bodies. Human Gene Therapy. 10: 559-63. PMID 10094199 DOI: 10.1089/10430349950018634  0.065
2004 Nakamura T, Peng KW, Vongpunsawad S, Harvey M, Mizuguchi H, Hayakawa T, Cattaneo R, Russell SJ. Antibody-targeted cell fusion. Nature Biotechnology. 22: 331-6. PMID 14990955 DOI: 10.1038/Nbt942  0.065
2015 Hickey RD, Mao SA, Amiot B, Suksanpaisan L, Miller A, Nace R, Glorioso J, O'Connor MK, Peng KW, Ikeda Y, Russell SJ, Nyberg SL. Noninvasive 3-dimensional imaging of liver regeneration in a mouse model of hereditary tyrosinemia type 1 using the sodium iodide symporter gene. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. 21: 442-53. PMID 25482651 DOI: 10.1002/lt.24057  0.065
2004 Peng KW, Holler PD, Orr BA, Kranz DM, Russell SJ. Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor. Gene Therapy. 11: 1234-9. PMID 15215883 DOI: 10.1038/Sj.Gt.3302286  0.064
2011 Hadac EM, Kelly EJ, Russell SJ. Myeloma xenograft destruction by a nonviral vector delivering oncolytic infectious nucleic acid. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1041-7. PMID 21505425 DOI: 10.1038/mt.2011.68  0.064
2010 Patel M, Jacobson BA, Sadiq AA, Raza A, Russell SJ, Kratzke RA. Oncolytic edmonston-strain measles virus as a novel therapeutic agent for non-small cell lung cancer. Journal of Clinical Oncology. 28: e13536-e13536. DOI: 10.1200/jco.2010.28.15_suppl.e13536  0.064
2010 Saloura V, Wang LC, Fridlender ZG, Sun J, Cheng G, Kapoor V, Sterman DH, Harty RN, Okumura A, Barber GN, Vile RG, Federspiel MJ, Russell SJ, Litzky L, Albelda SM. Evaluation of an attenuated vesicular stomatitis virus vector expressing interferon-beta for use in malignant pleural mesothelioma: heterogeneity in interferon responsiveness defines potential efficacy. Human Gene Therapy. 21: 51-64. PMID 19715403 DOI: 10.1089/Hum.2009.088  0.064
2016 Gonsalves WI, Rajkumar SV, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Dingli D, Go RS, Leung N, Kapoor P, Hayman SR, Lust JA, Russell SJ, Zeldenrust SR, Hwa YL, et al. Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy. Bone Marrow Transplantation. PMID 27064687 DOI: 10.1038/bmt.2016.91  0.064
2014 Lieder F, Plunkett D, Hamrick JB, Russell SJ, Hay NJ, Griffiths TL. Algorithm selection by rational metareasoning as a model of human strategy selection Advances in Neural Information Processing Systems. 4: 2870-2878.  0.064
2013 Escobar-Zarate D, Liu YP, Suksanpaisan L, Russell SJ, Peng KW. Overcoming cancer cell resistance to VSV oncolysis with JAK1/2 inhibitors. Cancer Gene Therapy. 20: 582-9. PMID 24030211 DOI: 10.1038/cgt.2013.55  0.064
2016 Hickey RD, Mao SA, Glorioso J, Elgilani F, Amiot B, Chen H, Rinaldo P, Marler R, Jiang H, DeGrado TR, Suksanpaisan L, O'Connor MK, Freeman BL, Ibrahim SH, Peng KW, ... ... Russell SJ, et al. Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1. Science Translational Medicine. 8: 349ra99. PMID 27464750 DOI: 10.1126/Scitranslmed.Aaf3838  0.063
2006 Szécsi J, Drury R, Josserand V, Grange MP, Boson B, Hartl I, Schneider R, Buchholz CJ, Coll JL, Russell SJ, Cosset FL, Verhoeyen E. Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactions. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 735-44. PMID 16784893 DOI: 10.1016/j.ymthe.2006.04.007  0.063
2013 Kourelis TV, Kumar SK, Gertz MA, Lacy MQ, Buadi FK, Hayman SR, Zeldenrust S, Leung N, Kyle RA, Russell S, Dingli D, Lust JA, Lin Y, Kapoor P, Rajkumar SV, et al. Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 4319-24. PMID 24145344 DOI: 10.1200/Jco.2013.50.8499  0.063
2020 Elsedawy NB, Nace RA, Russell SJ, Schulze AJ. Oncolytic Activity of Targeted Picornaviruses Formulated as Synthetic Infectious RNA. Molecular Therapy Oncolytics. 17: 484-495. PMID 32529026 DOI: 10.1016/j.omto.2020.05.003  0.063
2014 Liu YP, Wang J, Avanzato VA, Bakkum-Gamez JN, Russell SJ, Bell JC, Peng KW. Oncolytic vaccinia virotherapy for endometrial cancer. Gynecologic Oncology. 132: 722-9. PMID 24434058 DOI: 10.1016/j.ygyno.2014.01.009  0.063
2006 Iankov ID, Blechacz BR, Griesmann GE, Federspiel MJ, Russell SJ. 58. Oncolytic Measles Virus Delivery by Infected Cell Carriers–A Strategy To “By-Pass” the Pre-Existing Humoral Immune Response Molecular Therapy. 13: S24-S25. DOI: 10.1016/j.ymthe.2006.08.073  0.063
2017 Sidana S, Tandon N, Gertz MA, Dispenzieri A, Buadi FK, Lacy MQ, Dingli D, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Hwa YL, Kapoor P, Kyle RA, Leung N, ... ... Russell SJ, et al. Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis. Bone Marrow Transplantation. PMID 29269795 DOI: 10.1038/S41409-017-0020-5  0.063
2017 Lakshman A, Singh PP, Rajkumar SV, Lacy MQ, Gertz MA, Buadi FK, Dingli D, Dispenzieri A, Hwa L, Fonder A, Hobbs M, Zeldenrust S, Lust JA, Russell SJ, Leung N, et al. Efficacy of VDT PACE-like Regimens in Treatment of Relapsed/Refractory Multiple Myeloma—a Single Center Experience Blood. 130: 3096-3096. DOI: 10.1182/Blood.V130.Suppl_1.3096.3096  0.063
2010 Ricci D, Mennander AA, Miyagi N, Rao VP, Tazelaar HD, Classic K, Byrne GW, Russell SJ, McGregor CG. Prolonged cardiac allograft survival using iodine 131 after human sodium iodide symporter gene transfer in a rat model. Transplantation Proceedings. 42: 1888-94. PMID 20620544 DOI: 10.1016/j.transproceed.2009.12.065  0.063
2006 Iankov ID, Pandey M, Harvey M, Griesmann GE, Federspiel MJ, Russell SJ. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response. Journal of Virology. 80: 8530-40. PMID 16912303 DOI: 10.1128/JVI.00593-06  0.062
2014 Ayala-Breton C, Russell LO, Russell SJ, Peng KW. Faster replication and higher expression levels of viral glycoproteins give the vesicular stomatitis virus/measles virus hybrid VSV-FH a growth advantage over measles virus. Journal of Virology. 88: 8332-9. PMID 24829351 DOI: 10.1128/JVI.03823-13  0.062
2019 Muchtar E, Drake MT, Dispenzieri A, Lacy MQ, Buadi FK, Dingli D, Hayman SR, Kapoor P, Leung N, Jevremovic D, Fonder A, Hobbs MA, Hwa YL, Gonsalves WI, Warsame RM, ... ... Russell SJ, et al. Hypovitaminosis D Is Prevalent in Patients with Renal AL Amyloidosis and Associated with Non-t(11;14) Blood. 134: 5523-5523. DOI: 10.1182/Blood-2019-127668  0.062
2007 Schirmer JM, Miyagi N, Rao VP, Ricci D, Federspiel MJ, Kotin RM, Russell SJ, McGregor CG. Recombinant adeno-associated virus vector for gene transfer to the transplanted rat heart. Transplant International : Official Journal of the European Society For Organ Transplantation. 20: 550-7. PMID 17403107 DOI: 10.1111/J.1432-2277.2007.00479.X  0.062
Hide low-probability matches.